ASETEK - Share Capital Increase upon Exercise of Warrants

Reference is made to warrants issued by Asetek A/S, Danish central business register (CVR) no. 34880522 (the "Company"), pursuant to corporate resolutions adopted on October 8, 2013, August 12, 2014, August 11, 2015, April 28, 2016 and April 25, 2017 respectively. Pursuant to the applicable warrant terms, the warrants are exercisable in exercise windows open in a four weeks period running from the Company's preliminary announcement of its financial statements or publication of its interim financial report however no later than 7 years after the Subscription Date as specified in the Subscription Agreement, at 12 noon. Each warrant gives the holder the right but not the obligation, to subscribe for one share in the Company of a nominal value of DKK 0.1 at NOK 36.50. NOK 33.90, NOK 10.60, NOK 19.50 and NOK 76.25 per share respectively. The Company has now received exercise notices from warrant holders (employees in the subsidiaries Asetek Danmark A/S and Xiamen Asetek Computer Industry Co., Ltd.) aggregating 31,045 warrants distributed as follows: WarrantsWarrants issued on October 8, 2013 12,951Warrants issued on August 12, 2014 4,461Warrants issued on August 11, 2015 5,740Warrants issued on April 28, 2016 6,894Warrants issued on April 25, 2017 999In total 31,045 In respect of 5,284 exercised warrants issued on October 8, 2013, the Board of Directors has, in accordance with the applicable warrant terms, decided to pay the warrant holders a cash amount (cash settlement) corresponding to the amount by which the market price of the shares in the Company exceeds the subscription price, instead of delivering the shares corresponding to the warrants.  The holders of the remaining 25,761 exercised warrants will subscribe for the corresponding 25,761 shares of each nominally DKK 0.10 in the Company and the Company has received the following corresponding subscription price: Shares Subscription PriceWarrants issued on October 8, 2013 7,667 NOK 279,845.50Warrants issued on August 12, 2014 4,461 NOK 151,227.90Warrants issued on August 11, 2015 5,740 NOK 60,844.00Warrants issued on April 28, 2016 6,894 NOK 134,433.00Warrants issued on April 25, 2017 999 NOK 76,173.75In total 25,761 NOK 702,524.15 Consequently, the share capital increase resulting from the exercise of the warrants (from nominally DKK 2,552,189.70 by nominally DKK 2,576.10 to nominally DKK 2,554,765.80) will now be registered and the newly issued shares will be divided between the warrant holders having issued an exercise notice in accordance with the above. The shareholders’ register kept by the Norwegian central securities depository Verdipapirsentralen ASA and DNB Bank ASA respectively, the warrants’ register and the articles of association of the Company will be updated accordingly. Asetek A/SPeter Dam MadsenChief Financial Officer 

Fabege lett 16,500 sqm to Swedbank in Sundbyberg

Grand Central Sundbyberg is a new landmark in Sundbyberg city center. Its contemporary new design, featuring a new facade, expansive atriums, a roof terrace and open office layout, was the work of BAU Arkitekter. The building will also house an entrance to the commuter, underground and intercity railways, giving both employees and visitors very easy access to excellent communication options in all directions. Grand Central Sundbyberg will together with Swedbank's existing premises on Landsvägen 40 be the bank's headquarters. -         “We’re delighted that we were able to offer Swedbank a solution that meets their needs perfectly,” said Klaus Hansen Vikström, Fabege’s Vice President and Director of Business Development at Fabege. “The bank will have easy access to its second headquarter, excellent public transport links and the opportunity to fully customise a contemporary office building that already has a strong identity.”    -          “We are looking forward to working with Swedbank for many years to come and welcoming the bank's employees to Grand Central Sundbyberg,” commented Klaus Hansen Vikström, Vice President and Director of Business Development at Fabege. Grand Central Sundbyberg will satisfy the requirements for the environmental classification system BREEAM-SE Very Good. This means that there will be bicycle parking areas and a changing room, charging points for electric cars in the building and a sedum roof to reduce the impact on the city’s storm water system. The property listing for Grand Central Sundbyberg is Orgeln 7.  Fabege AB (publ)  

ASSA ABLOY acquires Mercury Security in the U.S.

ASSA ABLOY has signed an agreement to acquire Mercury Security, a leading OEM supplier of controllers for physical access control. "Mercury Security is a strategic technological addition to the ASSA ABLOY Group. The company reinforces our current offering, where Mercury Security considerably enhances the Group´s position within physical access control and will provide complementary growth opportunities,” says Johan Molin, President and CEO of ASSA ABLOY. “The acquisition of Mercury Security will advance HID‘s global leadership in the physical access control industry, adding Mercury Security’s high-quality controllers to HID’s product portfolio while extending HID’s installed base of millions of users beyond the readers and smart cards that we are already well known for,” says Stefan Widing, President and CEO of HID Global. Mercury Security was founded in 1992. It is headquartered in Long Beach, California and has some 45 employees. Sales for 2017 are expected to reach USD 60 million (approx. SEK 500 million) with a good EBIT margin. The acquisition will be accretive to EPS from start. The transaction is conditional upon regulatory approval and satisfaction of customary closing conditions and is expected to close during the fourth quarter of 2017.  For more information, please contact:Johan Molin, President and CEO, tel. no: +46 8 506 485 42Carolina Dybeck Happe, CFO and Executive Vice President, tel. no: +46 8 506 485 72  About ASSA ABLOYASSA ABLOY is the global leader in door opening solutions, dedicated to satisfying end user needs for security, safety and convenience. Since its formation in 1994, ASSA ABLOY has grown from a regional company into an international group with about 47,000 employees, operations in more than 70 countries and sales of SEK 71 billion. In the fast-growing electromechanical security segment, the Group has a leading position in areas such as access control, identification technology, entrance automation and hotel security.

Knorr-Bremse withdraws its Offer for Haldex and terminates merger clearance process

·  Haldex refuses to provide necessary cooperation in a continued merger clearance process ·  Offer cannot be completed within the current acceptance period Knorr-Bremse AG (“Knorr-Bremse”) withdraws its offer (the "Offer") to all shareholders of Haldex AB (publ) (“Haldex”) and abandons the proposed business combination. Knorr-Bremse will also not continue the merger clearance process. Knorr-Bremse has made this decision based on a careful assessment of all options and under consideration of the interests of all stakeholders following the resolution of the Swedish Securities Council (“SSC”). On 7 September 2017 the SSC had announced not to permit an extension of the current acceptance period whereby the Offer would lapse on 26 September 2017. Knorr-Bremse also carefully evaluated the SSC’s indication to permit Knorr-Bremse to revert with a new offer within three weeks of merger clearance. For the successful completion of the merger clearance process, the support and cooperation of Haldex and its Board, which surprisingly have been withdrawn, are indispensable and the key prerequisite. After the SSC decision, Knorr-Bremse had again reached out to the Haldex' Board with a request for necessary support and offered to explain the next steps in the merger clearance process and updated plans for the proposed combination. The Haldex Board has, however, denied this request for support and cooperation. The Haldex Board thereby continues to act against the majority vote of the extraordinary general meeting of Haldex, where shareholders had decided that Haldex is to support and cooperate with Knorr-Bremse in the merger clearance process. Without the cooperation and support of Haldex, merger clearance cannot be obtained. Completion of the Offer was conditional upon, inter alia, receipt of all necessary clearances from authorities on terms acceptable to Knorr-Bremse as well as Haldex not taking any measures that were likely to impair the prerequisites for implementing the Offer. These Offer conditions have not been met now and will clearly not be met within the acceptance period. Therefore, Knorr-Bremse withdraws the Offer and must terminate the merger clearance process. “We made an attractive offer, had convincing arguments and strong support by shareholders. We are convinced that the proposed combination would have been in the best interest of both companies as well as the shareholders of Haldex. Our approach was always, for sure, a friendly takeover. All our attempts to reach out to Haldex have, however, been rejected and the Board blocks to jointly continue and create a new driving force in the commercial vehicle sector.” said Klaus Deller, Chairman of the Executive Board of Knorr-Bremse AG. “It is thus a consequent step to withdraw the Offer and move on. The combination of Haldex and Knorr-Bremse would have been our preferred option which was clearly backed by the shareholders of Haldex. However, we will now pursue alternatives. With respect to our shareholding in Haldex we will act as a responsible shareholder and use all our options now at hand in the best interest of the company and Knorr-Bremse.” The shares that have been tendered in the Offer will hence not be acquired by Knorr-Bremse. The shares will remain in the possession of the shareholders who do not have to take any actions. Knorr-Bremse operates on the basis of a proven strategy that is fully geared towards profitable growth and at strengthening its footprint in the global commercial vehicle sector. Knorr-Bremse works at further expanding its offering for system solutions for which there is increasing customer demand. In addition, Knorr-Bremse will continue to put a strong focus on efficiency as well as safety and further drive innovation to support the equipment of commercial vehicles with more autonomous driving functions. Since 2012 Knorr-Bremse has invested around 6% of its annual sales in Research and Development. Already last fall Knorr-Bremse presented its solutions for autonomous yard manoeuvring and is in intensive talks with various customers. In addition, Knorr-Bremse will continue to push inorganic growth by screening the market for suitable bolt-on acquisitions. Background to the Offer: On 5 September 2016, Knorr-Bremse announced a public Offer to the shareholders of Haldex to tender all shares in Haldex to Knorr-Bremse. On 28 June 2017, Knorr-Bremse announced that it had received indications that the EU Commission might initiate a Phase II investigation and that in anticipation of the EU Commission’s decision to initiate a Phase II investigation, Knorr-Bremse applied for permission from the SSC to extend the maximum acceptance period until and including 9 February 2018. On 29 June 2017, the Haldex Board withdrew its support for the Offer and the continued merger control process. On 24 July 2017, the EU Commission informed Knorr-Bremse about the decision to initiate a Phase II investigation. At the extraordinary general meeting of Haldex on 17 August 2017 shareholders voted to support and endorse Knorr-Bremse’s application to the SSC regarding an extension of the acceptance period; furthermore shareholders instructed the Haldex Board to cooperate with Knorr-Bremse in the preparation of notifications to merger control authorities and the preparation of any relating remedies. On 7 September 2017, the SSC announced in its statement AMN 2017:27 not to permit an extension, but that it may allow Knorr-Bremse to revert with a new offer within three weeks of merger clearance. Knorr-Bremse AG  For additional information contact: Knorr-Bremse AG Eva DopplerEmail: Eva.Doppler@knorr-bremse.comPhone: +49 89 3547 1498 Additional contacts for media in Germany FTI Consulting SCCarolin AmannEmail: Carolin.Amann@fticonsulting.comPhone: +49 69 92037 132 Thomas M. KrammerEmail: Thomas.Krammer@fticonsulting.comPhone: +49 89 71042 2116 Additional contacts for media in Sweden ComirJohan HähnelEmail: Johan.Hahnel@comir.sePhone: +46 8 31 17 70 This press release was submitted for publication on 19 September 2017 at 8:00 CEST.  Important notice The Offer is not being made, directly or indirectly, in or into Australia, Canada, Hong Kong, Japan, New Zealand or South Africa by use of mail or any other means or instrumentality (including, without limitation, facsimile transmission, electronic mail, telex, telephone and the Internet) of interstate or foreign commerce, or of any facility of national security exchange, of Australia, Canada, Hong Kong, Japan, New Zealand or South Africa, and the Offer cannot be accepted by any such use, means, instrumentality or facility of, or from within, Australia, Canada, Hong Kong, Japan, New Zealand or South Africa. Accordingly, this announcement and any documentation relating to the Offer are not being and should not be sent, mailed or otherwise distributed or forwarded in or into Australia, Canada, Hong Kong, Japan, New Zealand or South Africa. This announcement is not being, and must not be, sent to shareholders with registered addresses in Australia, Canada, Hong Kong, Japan, New Zealand or South Africa. Banks, brokers, dealers and other nominees holding shares for persons in Australia, Canada, Hong Kong, Japan, New Zealand or South Africa must not forward this announcement or any other document received in connection with the Offer to such persons. Statements in this announcement relating to future status or circumstances, including statements regarding future performance, growth and other trend projections and the other benefits of the Offer, are forward-looking statements. These statements may generally, but not always, be identified by the use of words such as “anticipates”, “intends”, “expects”, “believes”, or similar expressions. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. There can be no assurance that actual results will not differ materially from those expressed or implied by these forward-looking statements due to many factors, many of which are outside the control of Knorr-Bremse AG. Any such forward-looking statements speak only as of the date on which they are made and Knorr-Bremse AG has no obligation (and undertakes no such obligation) to update or revise any of them, whether as a result of new information, future events or otherwise, except for in accordance with applicable laws and regulations. Special notice to shareholders in the United States  The Offer described in this announcement is made for shares of Haldex AB, a company incorporated under Swedish law, and is subject to Swedish disclosure and procedural requirements, which are different from those of the United States. The Offer is made in the United States in compliance with Section 14(e) of, and Regulation 14E under, the U.S. Securities Exchange Act of 1934, as amended (the “U.S. Exchange Act"), subject to the exemptions provided by Rule 14d-1(d) under the U.S. Exchange Act and otherwise in accordance with the requirements of Swedish law. Accordingly, the Offer is subject to disclosure and other procedural requirements, including with respect to withdrawal rights, the offer timetable, settlement procedures and timing of payments that are different from those applicable under U.S. domestic tender offer procedures and laws. To the extent permissible under applicable law or regulation, Knorr-Bremse AG and its affiliates or brokers (acting as agents for Knorr-Bremse AG or its affiliates, as applicable) may from time to time, and other than pursuant to the Offer, directly or indirectly purchase, or arrange to purchase, shares of Haldex AB, that are the subject of the Offer or any securities that are convertible into, exchangeable for or exercisable for such shares. To the extent information about such purchases or arrangements to purchase is made public in Sweden, such information will be disclosed by means of a press release or other means reasonably calculated to inform U.S. shareholders of Haldex AB of such information. In addition, the financial advisors to Knorr-Bremse AG, may also engage in ordinary course trading activities in securities of Haldex AB, which may include purchases or arrangements to purchase such securities. Knorr-Bremse AG and/or its affiliates or brokers have purchased shares of Haldex AB during the period following the announcement of the Offer on 5 September 2016. NEITHER THE UNITED STATES SECURITIES AND EXCHANGE COMMISSION NOR ANY U.S. STATE SECURITIES COMMISSION OR REGULATORY AUTHORITY HAS APPROVED OR DISAPPROVED OF THIS OFFER, PASSED UPON THE FAIRNESS OR MERITS OF THIS ANNOUNCEMENT OR DETERMINED WHETHER THIS ANNOUNCEMENT IS ACCURATE OR COMPLETE. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE IN THE UNITED STATES.

Nitro Games launches Medals of War!

"We’re proud to have Medals of War available for players now on App Store. This is the first release from our new portfolio and our first big self-published game. Therefore, this is a special and important moment for us.”  says Jussi Tähtinen, CEO and Co-Founder, Nitro Games Oyj. This launch follows Nitro Games’ strategy where the company is self-publishing it’s games in the western markets. Other markets, especially Asian countries, are planned to be accessed via publishing partners. Medals of War has been developed with Nitro Games’ MVP –process, where the game development is closely tied to continuously collecting actual market data and community feedback, as the game is being further developed. "It’s worth noting that this launch is just the beginning. With free-to-play mobile games the actual work starts at launch, and all hard work done this far has been about preparing for this journey. We’re looking forward to providing our players with new content, engaging events and a whole lot of fun time.” concludes Jussi Tähtinen. Medals of War is a community-focused game that brings players together with their friends. Players are matched with each other in intense PvP combat – In real-time! The aim is to level up and hone your skills to be the best commander in Warland. Find out more and follow us on: Facebook:  Twitter:  Website: 

Vattenfall joins EV100 to push for the transition to electric vehicles

The EV100 initiative aims to make electric vehicles "the new normal" under the support of the global non-profit organization The Climate Group. Magnus Hall, Vattenfall’s president and CEO says:“Vattenfall delivers solutions for sustainable and climate smarter living for customers and citizens. Climate change is one of our biggest challenges so we are very happy to join the EV100 initiative as electrical vehicles can make a significant contribution in reducing carbon emissions.” Vattenfall pledged in January 2017 to replace all its passenger and light commercial vehicles in Sweden, the Netherlands and Germany to electric alternatives. “We will replace the whole 3.500 car fleet to EV in the coming five years. With the decision we do not only contribute to reducing CO2-emissions in Europe, we also set an example for other companies. We work with our customers to deploy charging infrastructure and building northern Europe’s biggest connected charging network, InCharge,” says Magnus Hall, CEO Vattenfall. “We congratulate Vattenfall on being one of the first companies to join EV100. EV100 will use companies’ collective global buying power and influence on employees and customers to build demand and cut costs. The members being announced today see the business logic in leading a faster transition and addressing local air quality issues in their markets. They are setting a competitive challenge to the auto industry to deliver more EVs, sooner and at lower cost,” says Helen Clarkson, Chief Executive, The Climate Group. Facts:The ten first companies now joining The Climate Group's initiative EV100 are; Vattenfall, IKEA, Unilever, HP Inc., PG & E, Deutsche Post DHL Group, LeasePlan, Metro AG, Baidu and Heathrow Airport. The companies undertake to drive the development of electric cars towards 2030 in four areas; own fleet of vehicles, placing requirements on service contracts and to facilitate for employees and for customers to drive electric. More www.theclimategroup.orgVideo  with Tomas Björnsson, Head of E-mobility at Vattenfall Media inquiries, please contact:Vattenfall’s Press Office, telephone: +46 (0) 8 739 50 10, ( ( ( ( Twitter: 

Cell model of the brain provides new knowledge on developmental disease

Lissencephaly is a rare congenital developmental disease that can be caused by, amongst other anomalies, a mutation of the DCX gene. Affected individuals are born with serious developmental disabilities and a brain that is smooth instead of folded.  The discovery that it is possible to reprogramme specialised cells such as skin cells in order to reverse their development back to stem cells was rewarded with the 2012 Nobel Prize. The resulting so-called iPS cells (induced pluripotent stem cells) can then be turned into other specialised cell types.  Anna Falk, docent at Karolinska Institutet’s Department of Neuroscience, uses this technique to build cell models of the human brain. In the present study, her team took skin cells from patients with lissencephaly and turned them into iPS cells, which they then cultivated under special conditions into neuronal stem cells and neurons that are copies of those in the patients’ brains.  By examining the cell cultivation dishes, the researchers were able to observe how the patients’ cells behaved and developed from stem cells to nerve cells and compare them with cells from healthy controls. They found that the diseased cells matured much more slowly, sent out shorter projections and were much less mobile.   “It’s already known that DCX affects the ability of neurons to migrate, but we can now show that DCX plays a much greater, broader part in brain development than that,” says Dr Falk. “Our hypothesis is that it’s this, the damaged nerve cells’ resistance to maturation that causes the disease.”  Since there are no relevant animal models for lissencephaly, the reprogramming technique has been essential to the study of lissencephaly’s underlying pathogenesis. At Dr Falk’s laboratory, the method is used to also study other congenital diseases that affect the brain, such as autism and Down syndrome. In future projects, the researchers hope to study how diseased cells can be modified to act as healthy cells.  “What many developmental diseases have in common seems to be the failure of brain cells to mature at the same rate as they do in healthy people,” says Dr Falk. “Trying to influence the cells so that they behave like healthy cells is the first step towards some kind of therapy for these diseases.”  The study was a collaboration with Karolinska University Hospital, Uppsala University, SciLifeLab and the Salk Institute for Biological Studies in the USA. It was financed by several bodies, including the Swedish Foundation for Strategic Research, the Åke Wiberg Foundation, the Tore Nilson Foundation, the Jeansson Foundations, the Thuring Foundation and the Swedish Research Council, and through the KID and SFO funding schemes. Publication: ”An in vitro model of lissencephaly: expanding the role of DCX during neurogenesis” . M Shahsavani, R Pronk, R Falk, M Lam, M Moslem, S Linker, J Salma, K Day, J Schuster, B-M Anderlid, N Dahl, FH Gage, A Falk. Molecular Psychiatry, online 19 September 2017, doi: 10.1038/MP.2017.175.

Two Notorious Black-listed Fishing Vessels Ready to Resume Operations After Spanish Court Ruling

FOR IMMEDIATE RELEASE September 19, 2017 The Spanish National Court has ordered the payment of 700,000 Euros to a Chinese company in compensation for a cargo of illegally-caught Patagonian toothfish that was seized in Vietnam last year from a vessel owned by a Spanish fishing syndicate. Two other fishing boats from the same owners are now preparing to set sail after more than two years in detention in the Cabo Verde port of Mindelo. Marine conservation groups Oceana and Sea Shepherd are calling on the international community to immediately stop what they consider to be a gross miscarriage of justice. A government paying for an illegal cargo Last week, the Spanish National Court ruled that Vietnam authorities must transfer the value of the confiscated cargo of illicit toothfish unloaded by the Kunlun to the China-based company that purchased it. However, both Spain and The People’s Republic of China are contracting parties of the Commission for the Conservation of Antarctic Marine Living Resources (CCAMLR), which establishes that their nationals cannot benefit economically from any Illegal, Unreported and Unregulated (IUU) fishing. Oceana and Sea Shepherd strongly urge the governments of Vietnam, Spain and China to immediately cooperate to prevent a payment that is clearly in contravention of international agreements. “By ordering the payment of 700,000 Euros in compensation for a cargo of illegally-caught Patagonian toothfish, the Spanish National Court is sending the wrong signal to fishermen and the global fish market. There is no doubt that the confiscated fish was illegal since it lacked the documentation required to be traded legally. All international commitments to crack-down on IUU fishing are put at stake by the passive stance from Spanish and Chinese authorities. Instead Governments must stop illegal fishing now”, said Lasse Gustavsson, Executive Director of Oceana Europe. Black-listed vessels ready to operate this Austral summer The Spanish court ruling comes just as two other black-listed vessels historically connected to the same Vidal syndicate are preparing to resume fishing operations. Subjects of Interpol Purple Notices -- an international alert of criminal activity – the two vessels formerly named Yongding and Songhua have been detained in the Republic of Cabo Verde off West Africa since Sea Shepherd alerted the Cabo Verde Judicial Police to their operations in 2015 . However, Oceana and Sea Shepherd have recently discovered that these vessels have been repainted, renamed and reflagged. Yongding has been renamed Atlantic Wind and is now flagged to the Republic of Tanzania, while the Songhua has been renamed Pescacisne 2 and has been reflagged to Chile. “After having chased the Thunder in what became the longest maritime pursuit in history, I’ve come to know how these criminals operate,” said Captain Peter Hammarstedt, Director of Campaigns for Sea Shepherd Global. “The vessels formerly known as Yongding and Songhua have taken on crew and fishing gear. It is readily apparent that these two vessels are being readied for sea to poach again, emboldened by the decision of the Spanish National Court to reward criminal behavior”, Both Oceana and Sea Shepherd call on the government of Cabo Verde to not allow the vessels to proceed to sea and to deny them any sort of port support considering that both vessels are black-listed both under CCAMLR and under the International Commissions for the Conservation of Atlantic Tunas (ICCAT). They also call on the governments of Tanzania and Chile to de-flag the Atlantic Wind and the Pescacisne 2, respectively. “It took more than two decades of hard work from environmental NGOs and certain governments to get the international community united in the fight against IUU fishing,” says Gustavsson. “Yongding, Songhua and Kunlun are icons of this fight. If the international community doesn’t stop them they will plunder the Antarctic again and again.” Notes to the Editor In 2016, the Spanish Ministry of Agriculture, the Guardia Civil (Spanish Police) and Interpol launched lightening raids of properties belonging to the Spain-based Vidal fishing conglomerate. Thousands of documents and computer files were seized, six arrests were made, and the Spanish Ministry of Agriculture successfully imposed fines up to 17.8 million Euros as well as a 25-year ban from fishing and receiving government fishing subsidies for Vidal companies conglomerate. In parallel, the Spanish Prosecution Service launched a criminal case against shipowners for falsification of documents, money laundering, environmental crimes and criminal conspiracy. In the course of the investigation, an illicit cargo of 164 tons of presumably illegally-caught toothfish was also seized by Customs law enforcement agents in Vietnam at the request of the Guardia Civil through Interpol. The cargo was from an internationally-black listed, and Interpol-black listed fishing vessel named Kunlun. At the end of 2016, the Spanish Supreme Court dismissed the criminal case, albeit with one dissenting judge, stating Courts did not have the jurisdiction to rule on issues of illegal, unreported and unregulated (IUU) fishing in High Seas areas, such as the Antarctic. Therefore, in the opinion of the Court no crimes connected to IUU fishing in the High Seas could be prosecuted under Spanish law, including documented money laundering. ### Hi-res photos: - Atlantic Wind: Atlantic Wind, formerly the Yongding (photo: Sea Shepherd) - Yongding_Kadei_Jo_Watmore: The Yongding and the Songhua at Mindelo, Carbo Verde, 2015.  (photo: Josephine Watmore / Sea Shepherd) - Yongding 4_Jo_Watmore: Police and military board the Youngding (using the name Luampa), in Cabo Verde, 2015. (photo: Josephine Watmore / Sea Shepherd) For more information or interview requests contact: Heather Stimmler – Sea Shepherd Global Media DirectorTel +339 7719 7742Email: Marta Madina -- Oceana Communications DirectorTel: + 34 911 440 880 / +34 687 598 529Email: 

Boat Services strengthens team for catastrophe modelling shared service offering, Boat Oasis

Boat Services today announced the addition of Matt Jones and Bert Kerr as consultants to further develop the company’s fast growing catastrophe risk modelling business. Together they bring 30 years of industry expertise in (re)insurance catastrophe (cat) risk management to the Boat Oasis  platform. Boat Oasis is the multi-peril cat risk modelling platform, delivered by Boat Services, operating on the Oasis Loss Modelling Framework (LMF). The platform delivers a flexible, scalable and secure shared service that provides the (re)insurance industry with a cost-effective and reliable way to meet their risk modelling requirements. Following recent business momentum and platform growth, with the addition of vendors COMBUS, TigerEye and JBA, Matt Jones and Bert Kerr have been appointed to drive product development forward and ensure that any growth remains closely aligned with the needs of the clients. “Matt and Bert are joining us at the perfect time. Boat Oasis is building an ecosystem for the (re)insurance community and they will be pivotal in ensuring that the platform meets the needs of the market. I am excited to see the progress made over the coming months.” Jamie Khurshid CEO of Boat Services Ltd. Matt Jones joins Boat with over 20 years of (re)insurance industry experience, including 14 years at the Zurich Insurance Group. During this time, Matt took on various roles in the actuarial pricing and catastrophe risk management fields before becoming Global Head of Catastrophe Management. Matt graduated with a degree in Physics from the University of Nottingham and has a PhD in Oceanography and Remote Sensing from UCL. He is a qualified actuary and co-author of 'Natural Catastrophe Risk Management and Modelling: A Practitioner's Guide'. Bert Kerr has 10 years of catastrophe risk experience in the London market. During this time he has worked in a number of roles, including Head of Exposure Management positions for various Lloyds syndicates. For further information, please contact:Emmy GranstromMarketing ManagerBoat Services Ltd+44 (0)20 3735 ( About Boat Oasis Established in 2014, Boat Oasis delivers a flexible, scalable and secure catastrophe modelling shared service via a hosted and fully managed environment. Boat Oasis provides (re)insurance companies with the platform to gain a deeper understanding of their risk by accessing the best models from large and niche risk modelling providers around the world. This innovative offering represents a paradigm shift for catastrophe risk loss modelling within the global insurance industry, while bringing the reputation for excellence, reliability and quality from Cinnober’s traditional market within financial services. In 2014, Boat Services Ltd were approached to assist with the initial client evaluation that was successfully completed the following year. As of December 2016, Boat Services Ltd brought the Oasis LMF platform to market. For further information, please visit About Oasis Oasis is a global not-for-profit company limited by guarantee and owned by approximately 40 members who come from within the insurance and reinsurance community. Its mission is to create and foster links throughout the wide community of those interested in modelling catastrophic risk across business, academia, and government. For further information, please visit About Boat Services Boat Services Ltd is an independent service platform for the finance and (re)insurance industries, and is part of Cinnober, world leading independent provider of trading, clearing, and market surveillance solutions. Boat Services was established in 2007 in response to the regulatory pressures introduced when the financial regulation MiFID was implemented. Boat’s financial services include comprehensive MiFID and MiFID II trade reporting solutions. Since the acquisition of Boat by Cinnober in 2014, Boat have diversified beyond finance to include insurance services. For further information, please visit 

60 + 170 = future

September 2017 – One company group, two locations, two anniversaries: 60 years ago the lubricant specialist LIQUI MOLY was founded. MÉGUIN is almost three times as old. The mineral oil plant is celebrating 170 years of existence in 2017. Despite their advanced age, both German companies are in the best of health.There was a close relationship between the two independent companies of LIQUI MOLY and MÉGUIN for decades. As supplier, MÉGUIN produced the lubricants, predominantly motor oil, that LIQUI MOLY successfully sold throughout the world – more than just an addition to the additive business, the roots of LIQUI  MOLY.In 2006, both companies decided to combine their strengths and LIQUI MOLY took over MÉGUIN. Both brand names have remained. The merger was a far-reaching decision and a good one to boot, as from then on the growth curves knew only one direction: up. Between 2009 and 2016 sales increased by €256 m to €489 m - more than double."How fit a company is, as with people, depends on the way of life and personal attitude. Those who look after their mind and body have a better chance of a long life than those who burn the candle at both ends on a daily basis," says Ernst Prost, CEO and owner of both companies. LIQUI MOLY and he were both born in 1957 and neither feel in any way tired of life, but have instead remained young. Being fit, awake and open to changes is important for Ernst Prost: "This enables rapid adaptability. And that's what's decisive for the success and continuation of a company." Modernity means keeping in touch with the latest trends. "Of course, we can stand against the wind, but then the water will just lash us in the face. It is smarter to set the sails accordingly," says the company boss and cites globalisation as an example: "We did not order it, but we make use of the opportunities it offers with a great deal of joy and pleasure."Those who want to sail close to the wind have to adapt to changing weather conditions in a flash. With a big team, LIQUI MOLY and MÉGUIN now make up almost 800 people, this is only possible if responsibility is the highest maxim – keyword: subsidiarity principle. Flat hierarchies and short paths lead to fast decisions. "We maneuver on the market like a speed boat, not a sluggish oil tanker. Every day we adapt our course anew to meet the demands of our customers," says Ernst Prost. And this is necessary, because the medium-sized company is battling global oil corporations on a daily basis.To be successful under such conditions and over such a long period of time, MÉGUIN was founded in 1847, LIQUI MOLY in 1957, can only be done with unconventional thinking and acting. There are many examples: While the competition is relying more and more on sales reps, both companies are backing direct contact to the customer and are continuously expanding their sales teams - both in the domestic market of Germany and in other countries. And, again unlike competitors, both companies offer a free service hotline for technical questions on products, each in Ulm and in Saarlouis. No call centre, just a hotline staffed by experts.Investments in knowledge are of existential importance to the company group and are an expression of its forward-looking approach. "Discovering new products, that requires intensive research and that, in turn, requires the latest laboratory and production technology," says the CEO. For this reason the laboratory capacity has been doubled in recent years, a fuel depot has been set up at the harbor and the storage capacity in the oil factory has been significantly increased. The new matrix distribution and robot technology mean a quantum leap in production technology. Further projects are already underway."The roots of both companies are in Germany. Made in Germany is an important value for us," emphasizes Ernst Prost. The company group cherishes this as much as it does its general principles. These include respect, predictability, thankfulness and the Hanseatic commercial values. "These are values that have belonged together longer than our two companies, but that does not mean they are old hat to us," explains the owner, "instead we find that this practically makes us exotic nowadays, in the positive sense, mind you."What seems "old school" is actually modern and a question of the Zeitgeist. Whether this is met is continuously checked by the developers and marketing and sales experts at LIQUI MOLY and MÉGUIN, regularly turning everything upside down and questioning everything. The world is rapidly changing, and with it the taste and requirements of customers, particularly the young generations, or in other words, future customers. A hybrid additive is currently in development. Ernst Prost continued: "Recognizing the signs of the times and drawing the right conclusions from them. That is the key for a future-proof business and securing the existence of LIQUI MOLY und MÉGUIN."


Lund, Sweden, 12.00 CEST, 19 September 2017 – BONESUPPORT™, an emerging leader in innovative injectable bio-ceramic bone substitute products to treat bone voids caused by trauma, infection, disease or related surgery based on its unique CERAMENT® platform today announces that it has appointed Dr. Jerry Chang as its Executive Vice President of Research & Development. Dr Chang has more than 28 years of experience in the research, development and commercialization of medical devices in the orthopedic, regenerative medicine and biomaterials space. He joins BONESUPPORT from Zimmer Biomet Etex, a subsidiary of Zimmer Biomet that develops and commercializes products that address bone repair and regeneration. Etex was acquired by Zimmer Biomet in 2014. Dr Chang has worked for Etex and Zimmer Biomet Etex, as Vice President of Research & Development for over decade. During that period, Dr Chang has been involved in the development and launch of several bone and fracture healing products, including hardware solutions and curable calcium phosphate. He has also led the development of a number of combination products that contained biologics or cells to promote bone growth. Prior to Zimmer Biomet Etex, Dr Chang worked at Johnson & Johnson and Bristol-Myers Squibb ConvaTec. Dr Chang has published over 20 papers and has five issued US patents. Richard Davies, CEO of BONESUPPORT, commented: “We are delighted to welcome Dr. Chang to the team. We are confident his extensive experience in the creation and development of novel products and their launch worldwide will contribute greatly as we seek to expand our range of products on a global scale.” Dr. Jerry Chang, commenting on his appointment said: “I am very pleased to be joining BONESUPPORT to lead its R&D activities at this very exciting time for the Company. I have been extremely impressed with the CERAMENT platform given its proven ability to remodel to host bone and to deliver therapeutic agents, such as gentamicin, to protect the healing process. I am looking forward to bringing my significant experience and expertise to drive the development of the Company’s product pipeline, which are designed to deliver the next generation CERAMENT products that will enhance bone growth that are clearly needed to address multiple orthopedic indications.”  

LiPlaCis Phase 2 Recruitment Ongoing in DRP Screened Breast Cancer Patients: Relevant Clinical Benefits in 3 out of 5 Treated Patients

Early data from five evaluable included metastatic Breast Cancer patients predicted to be likely responders to LiPlaCis® shows: ·  One patient has a confirmed Partial Remission (PR, i.e. >30% reduction of her tumor) of 32 weeks.In addition to surgery and adjuvant treatment, the patient has received five prior medical treatments for her disease, with the best response being Stable Disease (i.e. no change in overall measurement of the tumor burden) The patient is suffering from a hard to treat tumor.  ·  Another patient has Stable Disease for >24 weeks. When SD > 24 weeks, patients are accounted for as responders. The patient is still receiving LiPlaCis® treatment. Prior to the LiPlaCis® treatment, the patient has received seven medical treatments of her disease, with the best response being Stable Disease (i.e. no change in the overall measurement of the tumor burden) Consequently, this is also a patient with a hard to treat tumor. Alongside a durable Stable Disease, this patient has clinical benefit of LiPlaCis® as metastases to the lung have resulted in production of fluid in the lungs (pleural effusion) which the patient needed to have removed.This is normally a repetitive procedure but since the LiPlaCis® treatment started, no thoracentesis has been needed. In addition, the patient has resumed a part-time work. ·  A third patient, currently with Stable Disease for 17 weeks, has metastases in the liver. At the time of inclusion in the study, her liver function values were severely elevated as a consequence of her cancer disease. This patient belongs to a fragile and hard to treat group of mBC patients. During treatment with LiPlaCis®, the liver enzyme values have all been normalized, demonstrating a clinical response. ·  One patient has a short Stable Disease (SD), and one patient had Progressive Disease (PD). It may be of interest that both these patients have previously received 12 prior treatments, including carboplatin - a cisplatin-like product - and may be resistant to treatment with LiPlaCis®.  · Five patients are currently receiving treatment in the study (are ongoing), whereof three have not yet been in the study for a sufficient time period to evaluate efficacy of LiPlaCis. Furthermore, data show that LiPlaCis® is well tolerated with mainly mild and only few moderate side effects (five grade 3 and no grade 4). “I’m excited about these early clinical results of LiPlaCis in hard to treat metastatic breast cancer and look forward to finalizing the study”, said MD, PhD Erik Hugger, Senior Consultant and Investigator at Vejle Hospital.  “I’m excited about these promising early results of the Phase 2 part of the LiPlaCis® study, where patients are screened as high likely responders before entering the trial”, says Peter Buhl Jensen, MD, PhD and CEO of Oncology Venture. “Several of the metastatic Breast Cancer patients are considered hard to treat, with seven to twelve lines of treatment before receiving LiPlaCis®. We are dedicated to developing new effective treatment options for these patients, guided by our Drug Response Predictor, DRP™. For LiPlaCis the goal is to obtain more than 10% response rate. My expectations are high for the DRP technology, as I believe it will bring new hope and better treatments for cancer patients”, comments Peter Buhl Jensen “I look forward to finalize the inclusion in the study later this month, and to report the final results as they mature.”, Buhl Jensen further comments.  Strong Support of Randomized Phase 2 in Breast CancerThe above data supports the ongoing LiPlaCis® development in collaboration with Cadila Pharmaceuticals LTD (“Cadila”) and Smerud Medical Research. Oncology Venture has entered a collaboration agreement with Cadila, according to which they will invest in research and development activities for 310 cancer patients, and DRP screening of more than 1400 patients. Cadila will perform four (4) Phase 2 trials in Prostate, Head & Neck, Skin and Esophageal Cancer, and a pivotal randomized clinical Phase 3 trial in metastatic Breast Cancer. As previously communicated, a total of 18 million SEK has been granted to OV’s LiPlaCis® project by Oncology Venture’s partner Smerud Medical Research and the EUROSTARS program. Oncology Venture and Smerud now begin preparations for a randomized Phase 2 in Breast Cancer, expected to include other European countries. LiPlaCis® Phase 2 for metastatic Breast Cancer (mBC)LiPlaCis® is an intelligent targeted liposomal formulation of cisplatin. LiPlaCis has finalized the dose escalation part of the trial, and has demonstrated promising activity in patients already in the dose escalation part. The drug is administered intravenously in three (3) week cycles on day 1 and day 8. Upon the investigator’s judgement, the patient may continue treatment for more than three (3) cycles when benefitting from it. LiPlaCis® has shown activity in Skin Cancer, Esophageal Cancer, Head and Neck Cancer, and Breast Cancer. Response (confirmed PR = Partial Response) has been published for the first DRP-screened patient with a hard to treat metastatic Breast Cancer. The drug has received status as a phase 2 study by the Danish authorities and three out of four planned Danish Medical Centers are now active in recruiting 12-15 metastatic Breast Cancer patients who are screened and expected to be highly likely responders to LiPlaCis®. The Phase 2 study in metastatic Breast Cancer expect to finalize its recruitment during Q3 2017. LiPlaCis® has been registered together with its DRP™ companion diagnostic for EU marking. Next step in the regulatory strategy is building a data package for a Pre-Submission meeting with the FDA. This will be done in collaboration with US experts. About the Drug Response Predictor - DRP™ Companion DiagnosticOncology Venture uses the Medical Prognosis Institute (MPI) multi gene DRP™ to select those patients who by the genetic signature of their cancer are found to have a high likelihood of responding to the drug. The goal is developing the drug for the right patients, and by screening patients before treatment the response rate can be significantly increased. This DRP™ method builds on the comparison of sensitive vs. resistant human cancer cell lines, including genomic information from cell lines combined with clinical tumor biology and clinical correlates in a systems biology network. The DRP™ is based on messenger RNA from the patient’s biopsies. The DRP™ platform, i.e. the DRP™ and the PRP™ tools, can be used in all cancer types and is patented for more than 70 anti-cancer drugs in the US. The PRP™ is used by MPI for Personalized Medicine. The DRP™ is used by Oncology Venture for drug development.   For further information, please contact Ulla Hald Buhl, COO Or Peter Buhl Jensen, CEOMobile: +45 21andChief IR & 60 89 22E-mail:CommunicationsMobile: 2170 About Oncology Venture Sweden AB Oncology Venture Sweden AB is engaged in the research and development of anti-cancer drugs via its wholly owned Danish subsidiary Oncology Venture ApS. Oncology Venture has a license to use Drug Response Prediction – DRP™ – in order to significantly increase the probability of success in clinical trials. DRP™ has proven its ability to provide a statistically significant prediction of the clinical outcome from drug treatment in cancer patients in 29 out of 37 clinical studies that were examined. The Company uses a model that alters the odds in comparison with traditional pharmaceutical development. Instead of treating all patients with a particular type of cancer, patients’ tumors genes are first screened, and only the patients most likely to respond to the treatment will be treated. Via a more well-defined patient group, risks and costs are reduced while the development process becomes more efficient. The current product portfolio: LiPlaCis® for Breast Cancer in collaboration with Cadila Pharmaceuticals, Irofulven developed from a fungus for Prostate Cancer, and APO010: an immuno-oncology product for Multiple Myeloma. Oncology Venture has spun out two companies as Special Purpose Vehicles: 2X Oncology Inc. is a US based company focusing on precision medicine for women’s cancers, currently with a pipeline of three promising phase 2 product candidates. OV-SPV 2 is a Danish company that will test and potentially develop an oral phase 2 Tyrosine Kinase inhibitor. This information is information that Oncology Venture Sweden AB is obliged to make public pursuant to the EU Market Abuse Regulation.The information was submitted for publication through the agency of the contact person set out above, on September 19th, 2017.

Saab explores the market for Gripen Aggressor to meet the US ADAIR requirement

There is a growing segment within the adversary air combat training market for highly advanced aggressor capabilities to be able to perform more realistic combat training. Gripen Aggressor, recently unveiled at the DSEI exhibition in London, UK, provides an exceptionally capable, dissimilar opponent aircraft system. It is able to perform the advanced combat maneuvering and networking tactics needed to represent a realistic peer or near-peer adversary threat for current and future pilots The USAF solicitation for ADAIR indicates the need for a high performance, highly capable dissimilar aircraft platform to meet the Level C requirements as outlined in the solicitation document. Fighter pilots need to train advanced combat tactics against peer and near-peer opponents, which is exactly what Gripen Aggressor can provide. Based on the proven Gripen C-series, the Gripen Aggressor has all the renowned handling and flight characteristics associated with the Gripen Fighter System, including its advanced sensor and datalink capabilities, but is specifically tailored to the adversary role. It will not carry live armament. Unlike the legacy platforms or current fighter platforms in use by the USAF, Gripen Aggressor, brings a distinctly different appearance and set of capabilities to the training scenario that will further enhance the proficiency of USAF pilots. Gripen Aggressor, with significant US content, shares many components and systems, including the engine, in common with existing US platforms. There is therefore a high level of logistic synergies that can act to reduce cost and maximize efficiency. Saab is currently exploring the market potential and business case for this unique capability and is in discussion with several potential partners to provide a solution. Visit the Saab Stand at the 2017 Air Force Association show to learn more about this exceptional aircraft and its capabilities. For further information, please contact: Saab Press Centre, +46 (0)734 180 018  Follow us on twitter: @saab  Saab serves the global market with world-leading products, services and solutions within military defence and civil security. Saab has operations and employees on all continents around the world. Through innovative, collaborative and pragmatic thinking, Saab develops, adopts and improves new technology to meet customers’ changing needs. 

Blossa 17 meets Old Delhi - Mango, cumin and chili give flavor to Blossa 17

On the narrow streets of Old Delhi bicycle rickshaws coexist with handcarts, mopeds and a lively crowd. In the middle of the old town lies Khari Baoli, Asia's largest spice market, where spices have been traded for over four centuries. - In India we find many of the flavors and spices that already exist in Blossa's glögg, such as cardamom, ginger and clove. In Blossa 17 Old Delhi, mango gives a note of tropical fruit, which both complements and contrasts beautifully with the traditional glögg spices. The spiciness of this year's glögg is further enhanced by cumin and ends with a distinct heat from chili. This is our interpretation of India, says Åsa Orsvärn, Chief Blender for Blossa. The shape and color of the bottle is inspired by traditional Indian sign painting, an old handicraft tradition in India where trucks, market stands and buildings are decorated with hand-painted patterns, symbols and messages. The design is made by Scandinavian Design Group, who has worked with Blossa's annual glögg since the start of the flavor journey in 2011. Before the reveal of 2017’s flavor and destination on September 19, Blossa was inspired by another art form that has grown strong in India: street art. Two street art artists were invited to Sweden from New Delhi in India with the mission to interpret Blossa 17 Old Delhi in a work of art. The result is a colorful blend of the hot India and the cold Nordics, with Blossa 17 as an exotic winter warmer in the darkness and the cold. The work of art is painted in several different layers that in different ways illustrate the flavor and the design of Blossa 17. The film showing how the whole work of art is created, can be seen at About Blossa Annual Every winter since 2003 Blossa has launched a new flavor. Up until 2010, Blossa has been inspired by the Nordic winter with flavors such as lingonberry, saffron and winter apple. Every year the bottle has been given a unique design and has, for many, become a collectible. From 2011, Blossa has looked out into the world and been inspired by different destinations. The classic glögg spices have been blended with new and exciting flavors from all corners of the world. In earlier years Blossa has visited, among other places, South America, Japan, France and England. Further Information: Nathalie Malledant, Category Brand Manager, Altia, +46 732 746 564 / Press images are available for download at:

Fazer recognised as Brand Builder of the Year

In its reasoning, the Finnish Association of Advertisers says that Fazer is making long-term investments in brand building, bravely adopting also new means. Fazer has a clear brand and communications strategy, the effects of which penetrate all the areas of its business. During the past few years, Fazer has focused on visibility in digital channels, reaching constantly growing audiences. Every Fazer employee is a brand ambassador for their part. President and CEO of the Fazer Group Christoph Vitzthum says: “We, all Fazer employees, are building the Fazer story with love. We are extremely pleased that our long-term attention to quality experiences, dialogue, content and brands has yielded results also in form of this award. It is great to be the Brand Builder of the Year in this special year, the centenary of Finland’s independence, especially considering we have devoted a lot to the festivities, both words and deeds.” Fazer’s most significant single brand and experience investment of 2016 was opening the Fazer Experience visitor centre. Fazer also launched an employee ambassador programme in social media (#meidänfazer). Each business area can boast successes: the popularity of the Fazer Root Vegetable Bread and the Doughnut Bar, Karl Fazer Milk Chocolate’s Travel series and new touching film, the more colourful personality of the Geisha brand, Fazer Food Services’ Culinary Team and Fazer Cafés’ favourite campaigns. Christoph Vitzthum explains: “We want to create meaningful food experiences that speak to people and bring joy and well-being into their lives. During the past few years, we have successfully increased our focus especially on digital channels and interaction – we create stories together with people. We want to generate discussion about the food of the future. Our Fazer Brainhow programme and the insect food video, which caught 415,000 viewers in social media, are great examples of this.” Fazer has been a pioneer in marketing ever since the company was founded in 1891. The esthetic and imaginative wrappers and packaging, cooperation with front-row artists and the first advertisements on trams are just a few examples of Fazer’s inventive emphasis on publicity that has been there from the very beginning. Fazer has always invested a lot in storytelling and taste memories and is one of Finland’s leading trademark registerers. Kiss-Kiss was registered as a trademark in 1901. It is Finland’s oldest trademark still in use. Additional information Ulrika Romantschuk, SVP, Communications & Branding, Fazer Group, tel.: +358 40 566 4246Fazer’s media phone line is open on weekdays from 8 to 16: +358 40 668 2998 #mainontapäivä #suomalaistahyvää #meidänfazer #fazerintarina #fazerjuhliisuomea 

Cxense ASA - company presentation with historical revenue figures for core business area

Oslo, Norway – 19 September 2017 – Cxense ASA (OSE: CXENSE) today released a new company presentation. The company presentation will be held at the DNB TMT Opportunity Conference in Dronning Eufemias gate 30, Oslo Norway on Wednesday 20 September 2017 11:20 CET. The presentation includes historical quarterly revenue development for the core business area, Data Management with Intelligent Personalization, which represents additional information on this business area as compared to the information released in the Q2 2017 report on 24 August 2017. About Cxense:Cxense helps hundreds of leading publishers and marketers across the globe transform their raw data into their most valuable resource. Cxense's leading Data Management Platform (DMP) with Intelligent Personalization, give companies unprecedented insight about their individual customers, and enables them to action this insight real-time in all marketing and sales channels. Benefits include increased digital revenue and user loyalty. Cxense works with brands such as Aeon, Wall Street Journal, Grupo Clarin, NBC Universal, Aller and many more. Cxense is headquartered in Norway with offices worldwide and the company is listed on the Oslo Stock Exchange with the ticker 'CXENSE.' For more information see www.cxense.comInvestor Relations Contact:Jørgen Loeng, Chief Financial OfficerEmail: ir@cxense.comMobile: +47 90 66 00 62

Cimco Marine AB (publ) further strengthens its position with new patent approval from the United States Patent and Trademark Office

The new patent (nr. 14/299246) covers intellectual property on Cimco’s latest hydraulic transmission design. – Cimco attaches great importance to global patent work as this strengthens the company's position and enhances its competitiveness in the long run. This approved patent, complements our existing patents and further strengthens our position in the global market, says Cecilia Anderberg, CEO of Cimco Marine. For further information, please contact:Cecilia Anderberg, CEO Cimco Marine AB, +46 763-10 22 50, Andreas Blomdahl, Chairman of the Board of Cimco Marine AB, +46 706-28 01 30,andreas@marinediesel.nuLars Sjögrell, Head of Public Relations, Cimco Marine AB, +46 702-69 53 00, Certified Adviser Västra Hamnen Corporate Finance AB is Certified Adviser for Cimco Marine AB. Cimco Marine AB (publ), is obligated to make this information public pursuant to the EU Market Abuse Regulation. The information was provided by the contacts above, to be submitted for publication on September 19th, 2017 at 4:00 PM. Cimco Marine AB (publ) has, after several years of development, constructed the OXE Diesel, the world's first diesel outboard engine in the high power segment. OXE Diesel has a unique belt driven propulsion system that allows a hydraulic multi-friction gearbox to be mounted. This means that the engine can handle significantly higher loads than a traditional outboard engine. Cimco's OXE Diesel has a horizontally mounted engine as opposed to a traditional outboard with a vertically mounted engine.

Kährs Group appoints new CFO

Peter Ericsson most recently held the position as Communication and Compliance Director for Kährs Group and he has also previously been CFO for the Group. Prior to joining Kährs, he held positions within Alecta Investment Management and KPMG. “I am glad to appoint Peter Ericsson as CFO. His experience from previous leading positions in the Group will be an asset in our continued development of Kährs,” says Christer Persson, President and CEO. Peter Ericsson has been a member of Group management since 2007 and will continue as part of management in his new role as CFO. He replaces Torbjörn Clementz who leaves Kährs. "I want to thank Torbjörn for his contributions and wish him luck in his future career," Christer Persson continues. For further information, please contact:Christer Persson, President and CEO, tel: +46 70 271 20 14 About Kährs GroupKährs Group is a world-leading flooring manufacturer in hardwood and resilient flooring with a number of strong brands in its product portfolio, including Kährs, Karelia and Upofloor. The Company's innovations have shaped the industry throughout history and Kährs Group is dedicated to providing the market with innovative new flooring solutions. Kährs Group, which delivers products to more than 70 countries, is the market leader in Sweden, Finland, Norway and Russia and holds a strong position in other key markets, such as the UK and Germany. The Group has approximately 1,700 employees and annual sales of EUR 300 million.

Brunswick Real Estate voted Best Nordic Real Estate M&A Adviser and Investment Manager

The 2017 Euromoney Real Estate Awards canvasses the opinions of more than 2,000 advisors, developers, investment managers, banks, and corporate end-users of real estate from more than 75 countries. Brunswick Real Estate was voted number one in nine categories:  Euromoney Real Estate Awards 2017 won by Brunswick Real Estate · Best Real Estate M&A Adviser – Nordic & Baltic  · Best Real Estate M&A Adviser – Sweden  · Best Real Estate Research – Sweden · Best Real Estate Adviser Overall, Banks – Sweden  · Best Real Estate Adviser Overall, Advisers & Consultants – Sweden  · Best Real Estate Agency/Letting Advisers & Consultants – Sweden   · Best Real Estate Investment Manager – Nordic & Baltic · Best Real Estate Investment Manager – Sweden  · Best Real Estate Loan Financing – Sweden    Brunswick Real Estate is a market leading group within real estate advisory, investment management and debt financing in the Nordics. In 2017, Leimdörfer, Sveafastigheter and Brunswick Real Estate Capital changed name to Brunswick Real Estate and formed a one-stop partner for both Nordic and international real estate investors in the Nordic region. Erik Eliasson, Partner Brunswick Real Estate Investment Banking Advisory: “We are pleased that our clients and peers once again have recognised us as the leading financial adviser for Nordic real estate related transactions. The survey highlights that Leimdörfer’s values, built over 25 years, are firmly established in our broad Brunswick Real Estate offering. We are experiencing strong investor appetite for Nordic real estate and will continue to work hard to always try and exceed our clients’ expectations.” Louise Richnau, Partner Brunswick Real Estate Debt Investment Management:“The interest in institutional funding has grown sharply since we started 2013 as the first party in the Nordic region providing real estate senior debt. It is therefore very pleasing with the appreciation that clients and investors provide expressed in Euromoney's award." Johan Tengelin, Partner Brunswick Real Estate Equity Investment Management: "Euromoney's survey is reputed as the benchmark in the global real estate industry, so we are pleased to be once again ranked number one. We work hard to create value for our investors, as well as for our tenants, in the properties we manage. This is proof that our strategy of active and local management is both successful and appreciated." For more information about Euromoney Real Estate Survey 


Q-Free ASA and the Norwegian Public Roads Administration (NPRA) have today settled a dispute related to invoicing of services for the central system for toll collection in Norway from 2006 to July 2016. Reference is made to note 13 in Q-Free’s Q4-16, Q1-17 and Q2-17 reports. Per the settlement agreement, Q-Free will pay NOK 27.8 million to the NPRA. A main reason for this is that Q-Free unintentionally miscalculated the invoice amount for some initial change orders. Over the years these initial errors have aggregated into a significant amount. The settlement amount will be paid in four installments over the coming 12 months, one per each of the next four quarters. Q-Free will book the settlement amount as a loss in the third quarter of 2017. With the signing of the settlement agreement, all issues related to Q-Free’s invoicing of central system services up until July 2016 are resolved. Q-Free and the NPRA are pleased to close this case and look forward to continuing their cooperation. For further information, please contact: President & CEO, Håkon Volldal: +47 977 19 973  About Q-Free Q-Free is a leading global supplier of Intelligent Transportation Systems. The company has approximately 420 employees, offices in 20 countries, and presence on all continents. Headquartered in Trondheim, Norway, Q-Free is listed on the Oslo Stock Exchange under the ticker QFR. Twitter: @Q-FreeASA

RayCare oncology information system to be shown at ASTRO 2017

During 24–27 September, RaySearch will be exhibiting at the ASTRO 2017, the Annual Meeting of the American Society for Radiation Oncology, in San Diego, US. Among other highlights, the company will present its next-generation oncology information system, RayCare®*, which will be released in December 2017. Attendees are welcome to visit RaySearch at booth #1647 and demonstrations can be booked now at The next-generation oncology information systemRayCare is a machine-learning oncology information system created to support every step of cancer care and enable truly comprehensive treatment organized around each patient’s needs. RayCare integrates seamlessly with RayStation, but that’s just the start. The system is designed to connect all the oncology disciplines, fluidly coordinate tasks and ensure optimal use of resources. RayCare will consolidate the multiple software systems that are commonly in use, including systems for medical oncology, radiation oncology and surgical oncology. Integrating the varied activities in these workflows saves time, reduces complexity and minimizes the risk of errors that can occur when transferring information between systems. And with a wide range of data immediately accessible to everyone who needs it, RayCare will bring adaptive treatment within reach for every clinic. RayStation 6: harmonizing treatment planningThe latest RayStation innovations will all be on show at ASTRO. Key features in RayStation 6 include support for TomoTherapy. This addition made RayStation the only system to enable planning for both conventional linacs and TomoTherapy systems, giving one point of control for all treatment planning activities. RayStation 6 also features MR-based planning, which makes it possible to use an MR image as the planning image for photon therapy as well as simultaneous optimization of multiple beam sets for SMLC, DMLC and VMAT. Other highlights include Monte Carlo dose calculation for proton pencil beam scanning (PBS) and PBS planning with block apertures. Automated planning and Plan ExplorerRayStation has extensive automated planning features that help optimize workflows and create new treatment possibilities. Plan Explorer, for example, makes it possible to automatically generate a large number of high-quality treatment plan alternatives, saving valuable time and giving the clinician a wide range of options to consider. Adaptive therapyRayStation is designed to make adaptive therapy easy to implement and perform in clinical practice. At the RaySearch booth, attendees can discover how automation features and smart tools in the fully integrated dose tracking and adaptive planning modules make it straightforward to get started.

Attorney Georgianna Junco-Kelman and Chef Frank Leon Host “Cali-Cubans for Cuban Hurricane Relief” Benefit on Sept. 28 at Ceremony Bar in Studio City

September 19, 2017 (LOS ANGELES) – The Cali-Cubans for Cuba Hurricane Relief fundraiser, organized by the Law Offices of Georgianna Junco-Kelman  in partnership with Friends of Caritas Cubana,  seeks to raise vital funds to assist the rebuilding efforts of the Cuban people. Every dollar raised will be earmarked exclusively for those who have been devastated by Hurricane Irma in Cuba. Restaurateur and renowned Chef Frank Leon is the leading event sponsor who will open the doors of his Studio City restaurant, Ceremony , on Thursday, September 28, 2017 at 6:30 pm. The festivities will include dinner, hosted cocktails, a cigar lounge, live music, dancing, entertainment, a fund the mission moment, and opportunity drawings. Throughout this very special Cuban-inspired evening, guests will enjoy traditional Cuban rhythms by DJ David Gonzalez and a live performance by Cuban Composer Carlos Jose Alvarez. Additional VIP guests slated to attend include actress Maria Canals Cabrera , “Your Cuban Abuelita” Jenny Lorenzo , Dodger’s player Yasiel Puig , actress Tessie Santiago , and many others to be announced. For additional details, visit Cali Cubans for Cuba Hurricane Irma Relief on Facebook . Individual tickets are priced at $100.00 (includes dinner and hosted bar). A limited amount of VIP tables are available for $1000.00 (includes 4 guests plus table server). To purchase tickets or donate, visit "The impact of Hurricane Irma on the Cuban people has been particularly devastating, both in terms of immediate living conditions and longer-term rebuilding,” stated Consuelo Isaacson, President of Friends of Caritas Cubana. “Caritas in Cuba has an unimpeachable record of delivering services directly to those most in need, and Friends of Caritas Cubana is their largest worldwide donor.  There simply is no better way to help those most impacted by the Hurricane." “I am grateful and honored to be a part of an incredible community of California Cubans who are coming forward with a generous spirit to help the people in our homeland of Cuba at a time of their greatest need,” stated Georgianna Junco-Kelman, attorney and creator of the Cali-Cubans Fur Cuba Hurricane Relief fundraiser. About Friends of Caritas Cubana Friends of Caritas Cubana is a 501 (c)(3) non-profit organization dedicated to enhancing the capacity of Caritas in Cuba to provide humanitarian, emergency, and social services to the people of Cuba. Caritas in Cuba provides humanitarian assistance to the most vulnerable citizens: the elderly, children, people with disabilities and autism and people living with HIV/AIDS. In addition to conducting programs for these populations, Caritas also provides emergency assistance/relief as needed in the aftermath of natural disasters and hurricanes. Friends of Caritas Cubana has actively supported Caritas in Cuba since 1999 and have received all necessary US Government licenses and approvals to conduct its activity with total transparency and in accordance with US and Cuban law. Visit: and follow us on Facebook: # # # Media Contact: Nikki Pesusich, Coterie Media |  818-788-7650 Sponsorships: Georgianna | (818) 386-2800  

Recipharm signs long-term manufacturing agreement with major new customer and acquires facility in Spain

Recipharm AB announces today that it has entered into collaboration with Roche and signed a long-term manufacturing agreement whereby Recipharm will manufacture a range of solid dose products. Recipharm will also acquire a manufacturing facility currently employing approximately 200 people located in Leganés, Spain, from Roche. The modern, well-equipped factory, located close to Madrid, currently produces solid dose products and is licensed to supply products globally to more than 95 countries.  Highlights · Long-term manufacturing agreement will add annual sales of approximately EUR 35 million corresponding to more than 6% of current Group sales and EBITDA-margin well in line with the Group’s overall target. · Adds a new important relationship with Roche. · Offers opportunity for collaboration with Recipharm’s facility in Parets, outside Barcelona and optimisation opportunities with Recipharm’s current solids manufacturing network. ”We are continuing to gain momentum in the CDMO market through our various profitable growth initiatives,” said Thomas Eldered, CEO Recipharm AB. “I am therefore delighted to announce this long-term agreement with Roche. It has become clear during our interactions with Roche that we are closely aligned in our ways of doing business, and we look forward to developing this relationship further by providing high-quality, reliable supplies from Leganés in future. In addition, we see a highly interesting business development opportunity to add new customers.” The acquisition of the manufacturing facility and the performance of the manufacturing agreement will be organised in a 100% owned subsidiary of Recipharm. Closing of the transaction and commencement of supply under the agreement is anticipated by the year end 2017. Contact informationThomas Eldered, CEO, telephone: +46 8 602 52 10Henrik Stenqvist, CFO,, telephone: +46 8 602 52 00 This information is information that Recipharm AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, on 20 September 2017, at 07:45 am CET. About RecipharmRecipharm is a leading Contract Development and Manufacturing Organisation (CDMO) in the pharmaceutical industry employing around 5,000 employees. Recipharm offers manufacturing services of pharmaceuticals in various dosage forms, production of clinical trial material and APIs, and pharmaceutical product development. Recipharm manufactures several hundred different products to customers ranging from big pharma to smaller research and development companies. Recipharm’s turnover is approximately SEK 5.3 billion and the company operates development and manufacturing facilities in France, Germany, India, Israel, Italy, Portugal, Spain, Sweden, the UK and the US and is headquartered in Stockholm, Sweden. The Recipharm B-share (RECI B) is listed on Nasdaq Stockholm. For more information on Recipharm and our services, please visit

New research: One child per school class contacted online by unknown adult wanting to arrange a physical meeting

Children spend an ever-greater proportion of their time on the Internet and social media. Tele2 commissioned Novus to undertake research in order to get a better picture of the everyday Internet experiences children in Sweden and the Baltics have, what they encounter online and the rules they have at home regarding their Internet usage. The research finds that one in every five children in Sweden has an unknown adult that follows them on social media and that on average one child per school class – or three percent of children – have been asked to physically meet by an unknown adult. One in ten children have also chatted with an unknown adult on social media. As well as coming in to contact with unknown adults, children are frequently in contact with things they view as “unpleasant or nasty”. Six in ten children responded that they have seen things on the Internet that they think are “scary or disgusting”. “This research report highlights the risks and vulnerabilities of children in the wake of their rapidly growing Internet usage. At Tele2, our view is that we need to take advantage of the opportunities offered by connectivity, while at the same time working actively to make life online as safe as possible for our children. As internet service providers, we have a key role to play in this context,” says Viktor Wallström, Vice President, Group Communications at Tele2 and board member at Wonsa, World of No Sexual Abuse. To address this issue, Tele2’s efforts include the blocking of Internet sites containing child sexual abuse content based on a list provided by Interpol. Every minute, Tele2 blocks on average 11 Internet pages. This corresponds to a little more than half a million pages each month in the eight countries in which Tele2 operates. On top of blocking Internet sites, Tele2 implements a detection function, something that can be done by all employers and means that all computers within the company are scanned to detect child sexual abuse content. Tele2 also seeks to contribute to an increased understanding of children’s Internet habits. A robust discussion about our children’s behaviour online is an important starting point in the efforts to strengthen children’s and young people’s safety online. The full research report is available here.  For more information, please contact:Angelica Gustafsson, Head of Public Relations, Tele2 AB, Phone: +46 704 26 41 42Erik Strandin Pers, Head of Investor Relations, Tele2 AB, Phone: +46 733 41 41 88 TELE2’S MISSION IS TO FEARLESSLY LIBERATE PEOPLE TO LIVE A MORE CONNECTED LIFE. We believe the connected life is a better life, and so our aim is to make connectivity increasingly accessible to our customers, no matter where or when they need it. Ever since Jan Stenbeck founded the company in 1993, it has been a tough challenger to the former government monopolies and other established providers. Tele2 offers mobile services, fixed broadband and telephony, data network services, content services and global IoT solutions. Every day our 17 million customers across 9 countries enjoy a fast and wireless experience through our award winning networks. Tele2 has been listed on the NASDAQ OMX Stockholm since 1996. In 2016, Tele2 had net sales of SEK 28 billion and reported an operating profit (EBITDA) of SEK 5.3 billion. For definitions of measures, please see the last pages of the Annual Report 2016. Follow @Tele2group on Twitter for the latest updates.

Essity and Microsoft partner on Internet of Things

Essity will implement Microsoft’s Azure cloud-based computing platform. Azure is a collection of integrated cloud services used to build, deploy and manage applications through Microsoft’s global network of data centers. Essity, which develops, produces and sells many of the world’s best-known hygiene and health products, including the global leading Tork and TENA brands, began to leverage big data to deliver smart solutions that help to improve the lives of people around the world four years ago, when it took an Internet of Things (IoT) approach to incontinence care for nursing home residents. Essity’s TENA Identifi was the first incontinence care product designed to electronically track a patient’s voiding patterns. The data is graphically converted into actionable, evidence-based reports to help nursing home staff optimize individualized continence care by ensuring that the right products are being used and that toilet routines are optimized, enhancing quality of life for nursing home residents. In 2014, Essity’s Tork brand, the world’s professional hygiene category leader, revolutionized facility cleaning by bringing an IoT approach to facility management in venues like stadiums, amusement parks, hospitals, airports and offices around the world. Through its award-winning Tork EasyCubeTM facility management software, Essity empowers cleaners and facility managers to track real-time data to ensure that soap and hand sanitizer, paper towels and bath tissue are never running on empty - lowering costs and improving consumer experiences. It enables them to deliver higher cleaning quality more efficiently by having real-time information on what is needed, when and where. This new data-driven cleaning also saves time and boosts the productivity and job satisfaction of janitorial staff.  “Every day, Essity is improving well-being for millions of people around the world through its innovative hygiene and health products and solutions. We are industry leaders in product design and quality, but in today’s digital world we know we need to push the boundaries of innovation even further. The cooperation with Microsoft will contribute to increased value and improved service for our customers and consumers. Through our strong commitment to research, development and digital innovations combined with our strong brands will facilitate people's everyday lives”, says Robert Sjöström, SVP Strategy & Business Development, Essity. “We’re proud to be chosen as a trusted partner on Essity's digital transformation journey. This collaboration will enable a new digital cloud platform for Essity to deliver even better products and services. By utilizing IoT and advanced data analytical solutions Essity have the capability to support their customers with world class hygiene and health solutions”, says Joacim Damgard, General Manager, Microsoft Sweden.  About Essity Essity is a leading global hygiene and health company that develops, produces and sells Personal Care (Baby Care, Feminine Care, Incontinence Products and Medical Solutions), Consumer Tissue and Professional Hygiene products and solutions. Our vision is; Dedicated to improving well-being through leading hygiene and health solutions. Sales are conducted in approximately 150 countries under many strong brands, including the leading global brands TENA and Tork, and other brands, such as Leukoplast, Libero, Libresse, Lotus, Nosotras, Saba, Tempo, Vinda and Zewa. Essity has about 48,000 employees and net sales in 2016 amounted to approximately SEK 101bn (EUR 10.7bn). The business operations are based on a sustainable business model with focus on value creation for people and nature. The company has its headquarters in Stockholm, Sweden, and is listed on Nasdaq Stockholm. Essity used to be part of the SCA Group. More information at About Microsoft Microsoft is the leading platform and productivity company for the mobile-first, cloud-first world, and its mission is to empower every person and every organization on the planet to achieve more. 

THQ Nordic completes a directed new share issue of 7,203,250 Class B shares, raising proceeds of approximately SEK 598 million

The reason for the deviation from the shareholders’ preferential rights are mainly to diversify the shareholder base among Swedish and international institutional investors and at the same time raise capital in a time efficient manner. The Company intends to use the proceeds from the Directed new share issue to finance new acquisitions of franchises and game development studios, as well as enable a higher rate of investment in the development of the Company. The completion of the Directed new share issue results in a dilution of approximately 9.1 per cent through an increase in the number of outstanding shares by 7,203,250 to 79,235,750 (divided into 9,000,000 Class A shares and 70,235,750 Class B shares following the Directed new share issue). In order to facilitate the delivery of shares to the investors in the Directed new share issue, Lars Wingefors AB will lend 7,203,250 Class B shares to Carnegie Investment Bank. The shares will be returned after the Directed new share issue has been registered with the Swedish Companies Registration Office. In connection with the Directed new share issue, the main owner and CEO Lars Wingefors and CFO Erik Stenberg has entered into a commitment not to sell their shareholdings during a lock-up period of 180 days.[1]  Advisers Carnegie Investment Bank AB (publ) has been appointed sole bookrunner and lead manager and Baker & McKenzie Advokatbyrå KB acts as legal counsel to the Company in connection with the Directed new share issue. For additional information, please contact: Lars Wingefors, Group CEO Tel: +46 708 471 978 E-mail:  About THQ Nordic THQ Nordic acquires, develops and publishes PC and console games. The company has a wide catalogue of 270 games, including 85 owned franchises, such as Darksiders, Titan Quest, MX vs ATV, Red Faction, Destroy All Humans, Aquanox, ELEX, Jagged Alliance, SpellForce and The Guild. THQ Nordic has a global publishing reach within marketing, sales and distribution, both online and offline. The group’s head office is based in Karlstad, Sweden and its operational office in Vienna, Austria. THQ Nordic employs and contractually collaborates with more than 480 people and has 6 inhouse development studios based in Germany, USA and Sweden. THQ Nordic shares are publicly listed on Nasdaq First North Stockholm under the ticker THQNB:SS with FNCA Sweden AB as its Certified Adviser. For more information, please visit: or This information is information that THQ Nordic is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 08.00 CET on September 20, 2017. Important information This announcement is not and does not form a part of any offer or solicitation to acquire, subscribe, sell or in any other way trade with shares or other securities in THQ Nordic. This document has not been approved by any regulatory authority and the information is not a prospectus in accordance with the requirements of EU Directive 2003/71 / EC. A prospectus be prepared for the Directed new share issue. This press release does not constitute or form part of an offer or solicitation to purchase or subscribe for securities in the United States. The securities referred to herein may not be sold in the United States absent registration or an exemption from registration under the US Securities Act of 1933, as amended. Immunovia does not intend to register any portion of the offering of the securities in the United States or to conduct a public offering of the securities in the United States. The information in this press release may not be announced, published or distributed, directly or indirectly, to the United States, Canada, Australia, New Zealand, Singapore, South Africa, Japan or Hong Kong or in any other jurisdiction where the announcement, publication or distribution of the information would not comply with applicable laws and regulations. ---------------------------------------------------------------------- [1]  The shares are owned by companies Lars Wingefors AB and Xagonus AB

Redwood Pharma to Attend Bio-Europe 2017, Nov. 6 - 8 in Berlin for Partnering Discussions

RP101 is the Company’s lead program for the development of a novel treatment of chronic dry eye disease in postmenopausal women. The active substance is an endogenous small molecule already proven safe and effective in two Phase II clinical trials conducted in the US. The active substance is being repurposed and has been formulated in IntelliGel to control its release, reduce dosing and increase compliance. Redwood Pharma will initiate a clinical Phase II trial of RP101 in Europe. Dry eye disease is a large market with serious unmet needs – estimated to grow to USD 2.7 billion in 2022. RP101 will be the first therapy targeted towards a unique biological mechanism and the target patient population of postmenopausal women. With prior development data, this program will be faster to market and has lower capital needs and development risks than programs based on New Chemical Entities. IntelliGel is Redwood Pharma’s exclusive technology for the topical delivery of drugs to the front of the eye using a novel hydrogel based on poloxamers and water. IntelliGel is applied as an eye drop and gels upon contact with the eye. This transparent, lubricating, reversible thermogel allows for better compliance with fewer doses of medicines since the gel keeps the active substance in the eye longer; it allows for a reduction in the amount of active substance administered, a lowering of the number of doses and possible side-effects related to active substance. IntelliGel is currently used in dermatological products commercially sold in the US and China. IntelliGel can be used for both prescription-based, as well as, OTC products.

Catena Media acquires Japanese affiliate

The acquired assets are some of the highest ranked casino websites in Japan. The business differentiate itself by publishing unique quality content aimed at Japanese players. The purchase price amounts to USD 5.5 million (about EUR 4.6 million), whereof USD 4 million will be paid upon transferring of the assets, and USD 1.5 million will be paid six months after completion of the transaction. The transfer of the assets and the initial payment is scheduled to take place in September 2017. The operation of the acquired assets currently generate quarterly sales of about EUR 350 000 with an operating margin of around 80 percent. All revenues stem from revenue share agreements. The acquired business, which started in 2006, has engaged a team of three full time employees, who will join Catena Media, and four freelance journalists. Furthermore, Catena Media will integrate its current Japanese domains into the newly acquired business, and thereby secure access to unique and valuable expertise. “This is a good example of an acquisition in line with our global growth strategy, and we will be well positioned for future expansion in Asia”, says Robert Andersson, CEO of Catena Media. For further information, please contact: Robert Andersson, CEOPhone: +356 770 329 28,E-mail: The information was submitted for publication on September 20, 2017 at 08.30 CET. About Catena Media Catena Media is an online performance marketing company that has established a leading position through strong organic growth and acquisitions. The business was started in 2012 and the group has approximately 250 employees in the US, Serbia, UK and Malta, where the Head Office is situated. In 2016, revenues reached EUR 40 million. The company is listed on Nasdaq Stockholm. Further information is available at

The Swedish Defence Materiel Administration orders crypto products worth 27 MSEK

SecuriVPN for nations information security Advenica's SecuriVPN system is used to protect the highest level of sensitive information within the Swedish Armed Forces, and is also approved for encrypted communication of the highest level of sensitive information within the EU. The SecuriVPN products feature high reliability, quantum safe technology, and easy-to-use administration and management. "Protecting information from advanced cyber-attacks has become an increasing challenge that organisations today must face. We are proud to contribute to Sweden's cyber defense with products such as SecuriVPN which is developed to protect organisations' most valuable information", says Andreas Häglund, VP Sales National Security, Advenica AB. By using network encryption, organisations can establish encrypted tunnels through open networks. Encrypted tunnels, Virtual Private Network (VPN), prevent any unauthorized data access or manipulation, enabling organisations to securely exchange classified information. For further information, please contact: Einar Lindquist, CEO Advenica AB, +46 (0)704 29 98 39, This information is information that Advenica AB is obligated to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 08.50 a.m. CET on September 20th, 2017.

Saab Receives Order for Giraffe 1X

“This Giraffe 1X contract further underlines Saab’s position as a supplier of world-leading protection against a wide range of air threats. Saab’s new generation of highly mobile surface radars is what defence forces around the world are asking for,” says Anders Linder, head of Surface Radar Solutions within Saab Business Area Surveillance. Giraffe 1X is a flexible and agile 3D active electronically scanned array (AESA) radar, featuring the latest in radar technology, including gallium nitride (GaN) circuits. Compact and lightweight with unparalleled performance, Giraffe 1X is suited for changing needs and mobile forces. The complete radar is portable and can be transported on a pickup truck-sized vehicle Saab’s combat-proven and highly regarded surface radar portfolio includes the renowned Giraffe, Sea Giraffe and Arthur radars. As one of the world’s leading radar suppliers with 60 years of experience, Saab has more than 3,000 radar systems in operation in 30 countries. For further information, please contact: Saab Press Centre, +46 (0)734 180 018  Follow us on twitter: @saab  Saab serves the global market with world-leading products, services and solutions within military defence and civil security. Saab has operations and employees on all continents around the world. Through innovative, collaborative and pragmatic thinking, Saab develops, adopts and improves new technology to meet customers’ changing needs. 

Thule Group Capital Markets Day – Summary of presentation

 “We have, as announced on June 2nd this year, finalized our strategic repositioning to become a pure branded consumer goods company, via the divestments of non-core businesses. At the same time we have been growing fast in some of the product categories within what has up to now been called Other Outdoor&Bags. We feel that the new structure with four Product Categories better represents the way the business is run in the two regions and will enable us to better communicate our ambition levels going forward.”, comments Magnus Welander, CEO and President.  New product category structure Product Previous structure Share of Sales GrowthCategory Thule Group (constant curr.) (2017Jun LTM) 2017H1 / 2016H1Sport&Cargo No change 65% + 7%CarriersPack, Bags Bags for Electronic Devices and 15% - 4%& Luggage part of Other Outdoor&BagsActive with Part of Other Outdoor&Bags 8% + 48%KidsRV Products Part of Other Outdoor&Bags 12% + 31% The overall ambition for Thule Group continues to be to drive profitable organic growth across all the categories, but as market trends and market position differs between the categories, the long-term ambitions in the four product categories are: · Sport&Cargo Carriers – Strengthen Global No.1 position · Packs, Bags & Luggage – Become a serious contender in Luggage and Daypacks · Active with Kids - Become a serious contender in Strollers · RV Products – Outpace the RV market Further insights into how management intends to achieve these overarching ambitions are outlined in the Capital Markets Day presentation.New Long-term Financial Targets – Thule Group“With our proven track record of organic constant currency sales growth above 5% in recent years and currently delivering an underlying EBIT-margin of 18%, which is above our current goal of 17%, we also felt it was time to update our new long-term financial targets.”, comments Magnus Welander. Sales growth ≥ 5%Yearly organic sales growth in constant currency (target not changed) EBIT-margin ≥ 20%Underlying EBIT-margin (previous target ≥ 17%) Net debt / EBITDA 1.5 – 2.5xLeverage Net Debt / EBITDA (previous target c. 2.5x) Dividend ≥ 50%Ordinary dividend as share of annual net income (target not changed)“We continue to see profitable organic growth as the No.1 focus for the company and thanks to a combination of economies of scale in an efficient and well-invested back-end of our business and an expected positive product mix shift going forward, we feel we have the key drivers to aim for a more ambitious long-term EBIT-margin target. Our proven strong cash generation and the focus on organic growth, while still being open to possible strategic M&A opportunities, are the main reasons behind the updated leverage target.”, adds Magnus Welander. 

GomSpace secures new innovation project from Innovation Fund Denmark

Today GomSpace A/S - a subsidiary of GomSpace Group AB (the ”Company”) together with Aalborg University and Pri-Dana Electronics A/S signed a contract with the Danish Innovation Fund for the Modular Advanced Radio for Satellite Services (MARS2) project. Under this project the partners will collaborate to develop unique technology, production capability and products to enable high bandwidth communication applications of nanosatellites. Innovation Fund Denmark is supporting the project with 27.000.000 DKK whereof GomSpace’s direct share is 10.000.000 DKK. The project will be executed over a 4 year period. For more information, please contact:Niels Buus (CEO)Tel: +45 40 31 55 57Email: nbu @ About Gomspace Group AB The Company’s business operations are mainly conducted through the wholly-owned Danish subsidiary, GomSpace A/S, with operational office in Aalborg, Denmark. GomSpace is a space company with a mission to be engaged in the global market for space systems and services by introducing new products, i.e. components, platforms and systems based on innovation within professional nanosatellites. The Company is listed on the Nasdaq First North Premier exchange under the ticker GOMX. FNCA Sweden AB is the Company’s Certified Adviser. For more information, please visit our website on Miscellaneous     +-----------------------------------------------------------------------------+|This information is information that GomSpace is obliged to make public ||pursuant to the EU Market Abuse Regulation. The information was submitted for||publication, through the agency of the contact person set out above, 09:00 ||a.m. CET on September 20, 2017. |+-----------------------------------------------------------------------------+

Helsinki signs agreement with Tencent to provide intelligent tourism services to Chinese tourists

Photo: Eetu Ahanen This cooperation combines Helsinki as an intelligent tourist destination with the media influence, product services and advanced technologies of Tencent. The cooperation will utilise network broadcasts, a WeChat official account, mini programmes, AR techniques, panoramic maps, big data and other related product services to provide convenient and diversified services for Chinese travellers. Users will be able to experience the urban culture of Helsinki through network broadcasts and other mobile product services, while a Helsinki mini application designed especially for travellers will be made available to almost one billion Tencent users. The mini programme will allow Tencent users to access important information about Helsinki and local services, as well as pictures, videos, maps, intelligent translations, one-touch SOS function and even online tax returns. Helsinki will also launch its own WeChat public account by the end of this year. Designated as City of Design in 2012 by UNESCO and described as the third coolest place to visit in 2017 by National Geographic Traveller, Helsinki is a modern city that offers functional design, unique gastronomy and maritime appeal. Helsinki also offers lively events all year round. “Cooperation with Tencent and WTCF is a huge opportunity for Helsinki to be seen on the biggest digital platform in China. We are very excited about this project. Our cooperation with the world’s top internet company Tencent, using its media promotion and product platform to display various aspects of Helsinki and serve Chinese outbound tourists, represents a great advance in innovation. Helsinki is the shortest and fastest route between Asia and Europe, which has helped Helsinki become the leading long-haul airport in Northern Europe. Launching this program will help make Helsinki as a destination and its attractions more accessible to Chinese travellers,” says Laura Aalto, CEO of Helsinki Marketing. Number of Chinese travellers to Helsinki continues to climb Helsinki has become increasingly popular among Chinese tourists in recent years. The number of registered overnight stays by Chinese travellers in Helsinki has more than doubled in the past five years, reaching almost 90,000 in 2016. During the first six months of 2017 alone, the number of overnight stays of Chinese visitors increased 43.6 percent compared to the same period in 2016. The growth of the number of Chinese visitors has been supported by Finnair’s focused Asian strategy, as a result of which flight connections between Helsinki and China are excellent. There are direct flights between 6 major Chinese cities (Beijing, Shanghai, Guangzhou, Hong Kong, Chongqing and Xi’an) and Helsinki, and Finnair will launch direct flights between Nanjing and Helsinki in May 2018. “Finnair’s direct flights from Helsinki to seven destinations in China create a strong base for attracting Chinese travellers to Finland. Helsinki’s future appearance on WeChat is an excellent way to raise awareness about Helsinki among Chinese travellers,” says Juha Järvinen, Chief Commercial Offer at Finnair. "Travel planning and decision-making in China have already moved onto mobile platforms, and the Finnish tourism industry should utilise this," Järvinen continues. Helsinki continues to strengthen its relationship with China The World Tourism Cities Federation (WTCF) has selected Helsinki to be the host city of its 2019 summit meeting. The decision was announced at this year’s summit in Los Angeles on 19 September 2017. “Helsinki joined the WTCF in 2014. Membership has already proven to be valuable, especially for enabling new business contacts and opening significant opportunities for cooperation in China. The importance of cities continues to grow, especially within the tourism industry, which is why it is important that Helsinki is part of this federation of tourism cities,” says Laura Aalto, CEO of Helsinki Marketing. The WTCF was founded in Beijing in 2012 with the aim of offering a platform for international tourism cooperation and promoting the sustainable development of tourism. The annual summit is widely publicised in China, so hosting the event offers Helsinki an excellent opportunity to gain visibility in China and attract high-level Chinese officials in connection with the meeting. Beijing and Helsinki have been sister cities since 2006.   Background information: Helsinki Marketing Helsinki Marketing is a marketing company owned by the City of Helsinki. Helsinki Marketing is responsible for Helsinki’s operative city marketing and business partnerships.  Official website: (The Chinese site will be launched by the end of 2017.)Image bank: Tencent Founded in November 1998, Tencent is a leading provider of online value-added services in China. Since its establishment, Tencent has maintained steady growth under its user-oriented operating strategies. Tencent provides social platforms and digital content services as part of its “Connection” strategy. Tencent’s leading Internet platforms in China – QQ (QQ Instant Messenger), Weixin/WeChat,, QQ Games, Qzone, and Tenpay – represent China's largest Internet community and meet the various needs of Internet users, including communication, information, entertainment, financial services and others. As of 31 March 2017, QQ had 861 million monthly active user (MAU) accounts while its peak concurrent user accounts reached 266 million. The combined MAU of Weixin and WeChat was 938 million. The development of Tencent has profoundly influenced the ways hundreds of millions of Internet users communicate with one another, as well as their lifestyles. It also offers possibilities of introducing a wider range of applications to the China’s Internet industry. Official website: World Tourism Cities Federation (WTCF) The WTCF was voluntarily formed by famous tourism cities and tourism-related institutions in the world under the initiative of Beijing. It is the world’s first international tourism organisation focusing on cities. Currently it has 128 city members, 65 institutional members and 6 branches. City members cover 62 countries and territories. Its institutional members include travel agencies, mass media, airports, airline companies, hotel groups, cruise companies and financial firms. Official website:   Contact Information: Laura AaltoHelsinki Marketing, CEOlaura.aalto@hel.fiMobile: +358 40 507 9660 Terry SunTencent, Director of Tencent Tourism Business Developmentterrysun@tencent.comMobile: +86 8217 3208 Jenny CaiWTCF, General Director, Public Relations & Brand Marketing +86 10 5155 0085 ext. 8408

Ericsson Study: How Network Slicing Pays Off

In a new study with operator BT, Ericsson (NASDAQ: ERIC) quantifies the benefits of network slicing for operators. When coupled with operational automation, network slicing is proven to be a smart investment to reduce operating expenditures and increase CAPEX efficiency, while enabling fast implementation and better utilization of devices related to the Internet of Things (IoT). Mobile data traffic continues to grow at a rapid pace along with adoption of connected devices. In the Ericsson Mobility Report , around 18 billion IoT devices are forecast by 2022. Connected IoT devices include connected cars, machines, meters, sensors, point-of-sales terminals, consumer electronics and wearables.   Network slicing allows operators to segment the network to support particular services and deploy multiple logical networks for different service types over one common infrastructure.  The joint study looked at three ways to introduce new services into a network: via one multi-service network; via individual networks with dedicated resources; or via network slicing including operational automation. Marielle Lindgren, Head of Ericsson United Kingdom, says: “We found that over a five-year period, introducing new services by using network slicing and operational automation generated 35 percent more revenue than by using one multi-service network. The revenue increased 15 percent when compared to several networks with dedicated resources, demonstrating how the technology enables market stimulation, faster time to market, and opportunities from smaller niche services.” Maria Cuevas, Head of Mobile Core Networks Research at BT, says: “We’re positioned to bring millions of devices onto our networks as the IoT ecosystem grows. This study gives us guidance as to where our investments will achieve the best results. The more services we deploy with network slicing, the greater economic benefit we will see, enabling us to better serve our customers. In order to achieve this vision, it is important that the industry provides cost-effective solutions to support end-to-end orchestration and adds automation to the operations and management of network slices.” 1-2-3 TO SAVE, GROW AND CONTRIBUTE Specifically, the study’s base case was a deployment ramping up to 40 annual service launches over five years. Network slicing resulted in the equivalent of 40 percent reduction in OPEX, 35 percent increase in revenue potential and an overall impact of 150 percent increased economic benefit, under the baseline assumptions made. When scaled up, the gains also increased. All benefits were considered in terms of the core network only. Marielle Lindgren continues: “As applications and use cases for evolving technology become more complex, so will the characteristics of connecting them. Simply put, networks will need to adapt. The findings clearly show that network slicing provides a logical setup that can be tailored to extend into the as-yet undefined services of the future.” Read the full report here  . NOTES TO EDITORS and BT  For media kits, backgroundersand high-resolution photos, please MORE INFORMATION AT:NewsCenter 10 719 69 92) 10 719 00 00) Ericsson is a world leader in communications technology and services with headquarters in Stockholm, Sweden. Our organization consists of more than 111,000 experts who provide customers in 180 countries with innovative solutions and services. Together we are building a more connected future where anyone and any industry is empowered to reach their full potential. Net sales in 2016 were SEK 222.6 billion (USD 24.5 billion). The Ericsson stock is listed on Nasdaq Stockholm and on NASDAQ in New York. Read more on

Invitation to the Pandox Hotel Market Day 2017

Pandox introduced the Hotel Market Day already in 1996 with the aim to reflect upon and analyse important macro trends and to contribute added know how to the hotel industry. Since then, the day has developed into a dynamic meeting place for decision makers within the international hotel industry. Please visit for more information and how to register. The event is open for participants from the hotel industry, investors, analysts and media. Please observe that the number of participants is limited. FOR MORE INFORMATION, PLEASE CONTACT: Anders Nissen, CEO, +46 708 46 02 02Anders Berg, Head of Communications and IR, +46 760 95 19 40Annelie Sundström, Executive Assistant, +46 737 07 97 78 The information was submitted for publication 20 September 2017, 10:00 CEST.About PandoxPandox is a leading owner of hotel properties in Northern Europe with a focus on sizeable hotels in key leisure and corporate destinations. Pandox’s hotel property portfolio comprises 122 hotels with approximately 27,000 hotel rooms in eleven countries. Pandox’s business is organised into Property Management, which comprises hotel properties leased on a long-term basis to market leading regional hotel operators and leading international hotel operators, and Operator Activities, which comprises hotel operations executed by Pandox in its owner-occupied hotel properties. Pandox was founded in 1995 and the company’s B shares are listed on Nasdaq Stockholm.

Alimak Group signs new construction order with Chalegrove Properties Limited to a value of SEK 41 million in the UK

Alimak Group, market leaders in vertical access solutions, has been awarded the contract to provide equipment and services on the flagship 75-story (239mtrs) residential skyscraper in Canary Wharf on the Isle of Dogs, London. The project will run until 2020 with most of the equipment being delivered during 2017. The order includes high performance Construction Hoists, Access Tower, service and support for the vertical access systems during the project. “This is the fourth large order we have received in Canary Wharf and the first from Chalegrove Properties Limited and we are proud to be involved on The Landmark Pinnacle which will be one of London’s tallest residential towers. The continued development of residential and office space in London is very exciting and we are pleased to see a continued interest in our solutions that are built to support safe and reliable vertical access during the construction period”, says Tormod Gunleiksrud, CEO, Alimak Group. For further information, contact: Stefan Rinaldo COO and acting CFO, Phone: +46 8 402 14 00 This information is information that Alimak Group AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, a 10:00 CET on 20 September 2017. About Alimak Group Alimak Group is a world-leading provider of vertical access solutions for industrial and construction industries. With presence in more than 100 countries, Alimak develops, manufactures, sells and provides service to vertical access solutions with focus on adding customer value through greater safety, higher productivity and improved cost efficiency. The Group´s products and solutions are sold under the brands Alimak Hek, CoxGomyl, Manntech and Avanti. Alimak has an installed base of more than 60,000 elevators, hoists, platforms, service lifts and building maintenance units around the world. Founded in Sweden 1948 Alimak has its headquarters in Stockholm, 12 manufacturing facilities in 8 countries and 2,400 employees around the world. 

British investor group Signal Special Opportunities new major owner in Swedish myFC

“We are very pleased to welcome Signal Special Opportunities as new major owner and to receive the continued support of Handelsbanken Fonder as we are about to enter into the phase of bringing our current main product JAQ Hybrid to the consumers. With this injection of capital, we can extend our investments in JAQ Hybrid as well as strengthen our other R&D activities. This includes the integration of our Lamina fuel cell in mobile devices and our efforts towards the automotive industry,” says Björn Westerholm, CEO of myFC. Signal Special Opportunities, a UK-based investment group, consists of a set of individual investors including the founders of Eshara Capital. “The need for green energy technology cannot be overestimated, particularly given recent government announcements on banning diesel and petrol cars in European cities as early as 2025. We see great potential in myFC’s hybrid platform and many possible applications for the company’s technology and fuel. We believe that electrification and the need for new technology to supplement batteries may be faster than current market forecasts,” says Alex Guy, CEO Eshara Capital. The new capital will primarily be used to further strengthen myFC's organization, in terms of both increased resources and competence in R&D, intellectual property rights management and marketing. The directed issue of in total 1,452,000 shares is done at a price of SEK 29 per share and executed with the authorization of myFC’s Annual General Meeting on May 22, 2017. Following the issue, the total number of shares in myFC will be 34,678,269. Signal’s ownership of 952,000 shares puts it at a share of 2.7% and Handelsbanken Fonder at a share of 5.7%. The dilution effect is 4.2%. This information is information that myFC is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, at 11:10 CET on September 20, 2017.

Citycon decided on a quarterly distribution

The Board of Directors of Citycon Oyj has today decided, on the basis of the authorisation by the Annual General Meeting 2017, that an equity repayment of EUR 0.0325 per share be distributed from the invested unrestricted equity fund of the company. The equity repayment will be paid to a shareholder registered in the company’s shareholders’ register maintained by Euroclear Finland Ltd on the record date for the dividend and equity repayment 22 September 2017. The equity repayment will be paid on 29 September 2017.Citycon’s Annual General Meeting held on 22 March 2017, resolved to authorise the Board of Directors to decide in its discretion on the distribution of dividend and equity repayment. Based on the authorisation the total amount of the dividend to be distributed shall not exceed EUR 0.01 per share and the maximum amount of equity repayment distributed from the invested unrestricted equity fund shall not exceed EUR 0.12 per share. The authorisation is valid until the opening of the Annual General Meeting 2018.Following the asset distribution on 29 September 2017, Citycon Oyj has distributed a total dividend and equity repayment of EUR 0.0975 per share during the year 2017 and the remaining authorisation of Citycon’s Board of Directors is EUR 0.0325 per share.Helsinki, 20 September 2017CITYCON OYJFor further information, please contact:Marcel Kokkeel, CEOTel. +358 40 154 6760marcel.kokkeel@citycon.comEero Sihvonen, Executive Vice President and CFOTel. +358 50 557 9137eero.sihvonen@citycon.comCitycon Oyj (Nasdaq Helsinki: CTY1S) is a leading owner, developer and manager of urban grocery-anchored shopping centres in the Nordic and Baltic regions, managing assets that total EUR 5 billion and with market capitalisation of EUR 2 billion. For more information about Citycon, please visit

Extraordinary general meeting in Cimco Marine AB

The extraordinary general meeting in Cimco Marine AB has today adopted the following resolutions.Directed share issueThe extraordinary general meeting resolved to approve the board's resolution on a directed share issue, as announced by the company on 4 September 2017. The resolution on the share issue means that the company's share capital is increased with not more than SEK 129,933.16 through an issue of 4,333,327 new shares. The total amount of the share issue is SEK 65 million. Entitled to subscribe for new shares are a number of investors of strategic importance. The reason for the deviation from the shareholders’ pre-emption rights is to, in a time and cost-efficient way, secure the company’s need of additional funding and to tie strategically important investors to the company. The shares are issued at a price of 15 SEK per share. The resolution was unanimously adopted. All shares have been subscribed for and the board has resolved to allot the shares in accordance with the resolution. The largest subscribers for this share issue were Per Lindberg, Prioritet Group AB, Magnus Linderoth and Sonny Johansson. After the share issue, the company will have 24,101,617 shares. Authorisation for the board to resolve on issues of shares/warrants/convertiblesThe extraordinary general meeting resolved to adopt the board's proposal to authorise the board to issue new shares, warrants and/or convertibles. Resolutions can be adopted one or several occasions during the time up until the next annual general meeting. The board shall have the right to resolve on new issues of shares, warrants and/or convertibles with deviation from the shareholders’ pre-emption rights and/or with provisions on payment in kind, by set-off of claims or otherwise on such terms and conditions as referred to in Chapter 2, Section 5, second paragraph, points 1-3 and 5, of the Swedish Companies Act. The total increase of shares that may be issued based on or as a result of this authorisation cannot in aggregate exceed 20 per cent of the number of outstanding shares after registration of the directed share issue described above. Issues based on the authorisation shall be made at market price, including market rate discount, if applicable. The board shall have the right to set the terms and conditions for issues under this authorisation as well as to decide who shall have the right to subscribe for the new shares, warrants or convertibles. The reasons for the board to resolve on issues with deviation from the shareholders’ pre-emption rights and/or with provisions on payment in kind, by set-off of claims or otherwise on such terms and conditions as referred to in Chapter 2, Section 5, second paragraph, points 1-3 and 5, of the Swedish Companies Act are to be able to carry out directed share issues to raise capital to the company and/or to strengthen the company's financial position. For further information about the share issue, please see Cimco's press release as of 4 September 2017. For further information, please contact: Cecilia Anderberg, CEO Cimco Marine AB, tel. +46 763-10 22 50, Andreas Blomdahl, Chairman of the Board of Cimco Marine AB, tel. +46 706-28 01 30, (,%20Advokatfirman%20Lindahl%20and%20member%20of%20the%20board%20of%20Cimco%20Marine%20AB,%3cbr%20/%3etel.%20+46%20702-79%2073%2094,,%20head%20of%20public%20relations,%20Cimco%20Marine%20AB,%20tel.%20+46%20702-69%2053%2000, Myron Mahendra, CFO Cimco Marine AB, tel. +46 763-47 59 82, myron.mahendra@oxe-diesel.comLars Sjögrell, Head of Public Relations, Cimco Marine AB, tel. +46 702-69 53 00, Certified Adviser Västra Hamnen Corporate Finance AB is Certified Adviser for Cimco Marine AB. Cimco Marine AB (publ), is obligated to make this information public pursuant to the EU Market Abuse Regulation. The information was provided by the contacts above, to be submitted for publication on September 20, 2017 at 3.15 PM.  Cimco Marine AB (publ) has, after several years of development, constructed the OXE Diesel, the world's first diesel outboard engine in the high power segment. OXE Diesel has a unique belt driven propulsion system that allows a hydraulic multi-friction gearbox to be mounted. This means that the engine can handle significantly higher loads than a traditional outboard engine. Cimco's OXE diesel has a horizontally mounted engine as opposed to a traditional outboard with a vertically mounted engine.

Boozt AB’s (publ) Nomination Committee appointed

In accordance with the resolution by the Annual General Meeting on May 15, 2017, Boozt’s Nomination Committee shall consist of representatives of the three, per August 31, 2017, by votes, largest shareholders according to the shareholders’ register held by Euroclear Sweden, and the Chairman of the Board. The Chairman of the Board shall also summon the first meeting of the Nomination Committee. In case one of the three largest shareholders refrain from appointing a representative, or such representative resign prior to completion of the assignment and without the shareholder who has appointed the representative appointing a new member, the Chairman of the Board of Directors shall encourage the next owner in size (i.e. in the first place the fourth largest shareholder) to appoint a representative. The procedure shall go on until the Nomination Committee is composed of four members including the Chairman of the Board of Directors. The member who represents the largest shareholder by votes shall be appointed Chairman of the Nomination Committee. The composition of the Nomination Committee shall be publicly announced no later than six months before the next Annual General Meeting. No remuneration shall be payable. The Nomination Committee has been formed in accordance with the principles adopted by the Annual General Meeting and has the following composition: · Bjørn Folmer Kroghsbo (representing Sampension KP Livsforsikring A/S), Chairman of the Nomination Committee · Christian Lindegaard Jepsen (representing Sunstone Technology Ventures II K/S) · Staffan Mörndal (representing Verdane Capital VII K/S) · Henrik Theilbjørn, Chairman of the Board of Boozt AB (publ) The Nomination Committee submits proposals to the AGM regarding the composition of the Board, remuneration of the Board, election of auditors and auditor fees. Shareholders who would like to submit proposals to the Nomination Committee can do so by e-mail or by letter to Boozt AB, Att: Valberedningen, Hyllie Boulevard 10 B, 215 32 Malmö, Sweden. The proposals of the Nomination Committee will be presented in the notice of the Annual General Meeting for 2018 and will be published on Boozt’s website. The Annual General Meeting will be held in Malmö on April 27, 2018. For additional information, please contact: Boozt AB (publ) Henrik Theilbjørn / Chairman of the Board / Phone: +45 22 80 02 73 / Email:  Johan Holmqvist / Head of IR & Corporate Communications / Phone: +46 708 37 66 77 / Email:  The information was submitted for publication, through the agency of the contact person set out above, at 16:30 CET on September 20, 2017.  About Boozt Boozt is a leading, fast-growing and profitable Nordic technology company selling fashion online. The Group generated net sales amounting to SEK 1.4 billion in 2016. Boozt offers its customers a curated and contemporary selection of fashion brands, relevant to a variety of lifestyles, mainly through its multi-brand webstore The company is focused on using cutting-edge, in-house developed technology to curate the best possible customer experience. With an active customer base of over 915,000 and counting, attracts more than six million visits per month. Besides, the company also runs the webstore and retail stores Booztlet and Beauty by Boozt in Denmark. For more information, please visit

Millicom issues 10-year corporate bond, completes tender offer and satisfies redemption condition

Title     CUSIP   ISINs     Principal     Principal   Principal Amount Amount Amount Tendered Purchased Remaining6.625%     600814AL1   US600814AL16;     $185,922,000     $185,922,000   $472,554,000Senior XS0980363344Notesdue2021 Millicom intends to use the remaining bond proceeds, plus cash on hand, to redeem all Notes that remain outstanding pursuant to the Conditional Redemption Notice that was delivered on 11 September 2017, and confirms that the condition described in the Conditional Redemption Notice has now been satisfied. The security identification codes for the new bond are: CUSIP numbers 600814AN7 and L6388GAB6, ISIN codes US600814AN71 and USL6388GAB60, and Common Codes 168724179 and 168724438. The Tender Offer was made on the terms and subject to the conditions set forth in the Tender Offer Memorandum dated 11 September 2017 (capitalized terms used in this announcement without definition have the meanings specified in the Tender Offer Memorandum). This press release is qualified in its entirety by the Tender Offer Memorandum. This press release will also be posted on the website of the Luxembourg Stock Exchange. This press release is for information purposes only and does not constitute an offer to purchase nor the solicitation of an offer to sell any of the securities described herein nor shall there be any offer or sale of such securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. The Tender Offer was made pursuant to the Tender Offer Memorandum, which sets forth the complete terms and conditions of the Tender Offer. Capitalized terms used in this announcement and not otherwise defined have the meanings ascribed to them in the Tender Offer Memorandum. Certain statements in this press release, including those describing the completion of the Redemption, constitute forward-looking statements. These statements are not historical facts but instead represent only Millicom's belief regarding future events, many of which, by their nature, are inherently uncertain and outside Millicom's control. It is possible that actual results will differ, possibly materially, from the anticipated results indicated in these statements.

MenaQ7® Full Spectrum Vitamin K2 to Launch at SupplySide West

OSLO, NORWAY and METUCHEN, NJ (September 21, 2017) – NattoPharma further strengthens its reputation as the most comprehensive Vitamin K2 supplier by introducing a breakthrough unlike anything on the market: MenaQ7® Full Spectrum K2. This latest innovation is the result of a proprietary technological breakthrough, creating a Vitamin K2 that provides menaquinones (MK) 6, 7, 8 and 9, a range of isomers vital for cardiovascular health. “NattoPharma has driven the creation of the Vitamin K2 market, sponsoring the important research validating the importance of K2 for human health, and this work has shaped the MenaQ7 brand,” says NattoPharma Chief Medical Officer Dr. Hogne Vik. “The important epidemiological studies that led us to our ground-breaking human clinical research used fermented cheese as the source of Vitamin K2, which led us to create MenaQ7 Full Spectrum.” According to researchers closely linked to these epidemiological studies1-3: “Vitamin K is a fat-soluble vitamin that plays and unequivocal role in the activation of Gla-proteins. Although all K-vitamins have the same function, they differ in bioavailability and bioactivity. “The Rotterdam and Prospect studies have shown that food-derived vitamin K (such as from cheeses) improves long-term cardiovascular health outcomes because it more specifically delivers the long-chain menaquinones MK-6, 7, 8 and 9.” “While fermented cheeses are the best dietary source of menaquinones in the West, most will not be able to consume enough to obtain optimal amounts of Vitamin K2, nor is cheese a practical source for extracting the menaquinones,” adds Dr. Vik. “To that end, NattoPharma has once again broken the mold and offers to the market a raw material that delivers the range of menaquinones found in foods.”  The first and only Vitamin K2 to deliver a gamut of menaquinone isomers, MenaQ7® Full Spectrum is naturally fermented using chickpea protein, offering an all-trans Vitamin K2 that is free from gluten, soy and all-known allergens, and is suitable for vegans and vegetarians. MenaQ7® Full Spectrum provides the vital menaquinone isomers MK-6, 7, 8 and 9 for optimal and maximal delivery of vitamin K2 with respect to absorption, half-life and biological activity. “NattoPharma has once again created a raw material that speaks directly to the natural dietary supplement consumer, who is drawn to comprehensive nutritional sources,” says Daniel Rosenbaum, NattoPharma CEO. “We welcome the opportunity to meet with companies at this year’s SupplySide West to officially launch this market-changing innovation.” MenaQ7® Full Spectrum Vitamin K2 will be centrepiece of NattoPharma’s SupplySide West booth P115.   References: 1 Geleijnse JM, Vermeer C, Grobbee DE, et al. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study. J Nutr. 2004;134:3100-5. 2 Beulens JW, Bots ML, Atsma F, et al. High dietary menaquinone intake is associated with reduced coronary calcification. Atherosclerosis. 2009;203:489-93. 3 Gast GC, de Roos NM, Sluijs I, et al. A high menaquinone intake reduces the incidence of coronary heart disease. Nutr Metab Cardiovasc Dis. 2009;19:504-10. # # # About NattoPharma and MenaQ7® NattoPharma ASA, based in Norway, is the world’s leader in vitamin K2 research and development. NattoPharma is the exclusive international supplier of MenaQ7® Vitamin K2 as MK-7, the best documented, vitamin K2 as menaquinone-7 (MK-7) with guaranteed actives and stability, clinical substantiation, and international patents granted and pending. The company has a multi-year research and development program to substantiate and discover the health benefits of vitamin K2 for applications in the marketplace for functional food and dietary supplements. With a global presence, the company established its North American subsidiary, NattoPharma USA, Inc., in Metuchen, NJ, and NattoPharma R&D Ltd. in Cyprus. For more information, visit or For more information, please contact: Kate Quackenbush, Director of Communications NattoPharma USA, Inc. Phone: 609-643-0749 E-mail:

Inflammatory bowel disease in childhood associated with increased risk of cancer

Adulthood onset inflammatory bowel diseases such as ulcerative colitis and Crohn’s disease have been associated with an increased risk of bowel cancer. However, there have been no studies showing how the cancer risk is affected by childhood onset of the disease and whether it changes over time. Using data from the Swedish National Patient Register, researchers at Karolinska Institutet have now compared the incidence of cancer in 9,405 individuals who were diagnosed with inflammatory bowel disease as children, with 92,870 individuals from the general population. Their results show that individuals who developed inflammatory bowel disease before the age of 18 had twice the cancer risk during childhood and adolescence as well as adulthood, compared with people who did not have such a diagnosis. The largest increase in risk was observed for bowel cancer, but there was also an increase in risk for other forms of cancer, such as blood and skin cancers. “We believe that the main cause is the chronic inflammation, which we know to be a driving factor for many different cancer types,” says principal investigator Ola Olén at Karolinska Institutet’s Clinical Epidemiology Unit at the Department of Medicine, Solna. “Early onset means that the body is exposed to inflammation for a longer time.” The study participants were diagnosed with inflammatory bowel disease between 1964 and 2014. “The treatment for inflammatory bowel disease improved considerably over these years, thanks in part to the introduction of new immunomodulating drugs, but unfortunately we can’t see that the relative incidence of cancer simultaneously declined,” says Dr Olén. Adult patients with inflammatory bowel disease are regularly invited to colonoscopy screenings, which can detect the presence of any cancer in the gut. The researchers believe that the knowledge of the cancer risk associated with the early onset of inflammatory bowel disease has to be factored into decisions on colonoscopy screening for children and adolescents, from both a healthcare and a patient perspective.” “Don’t forget that even if relative risks are high, the absolute risks are much more modest, and during childhood absolute risks are extremely small. Most young people don’t get cancer, and some of these forms of tumours are extremely rare,” explains Dr Olén. “But it’s probably important for individuals who develop inflammatory bowel disease in childhood to make sure to attend the examinations they’re invited to, especially those who have other strong risk factors for cancer, such as a family history of early cancer.” The research was financed by the Swedish Society of Medicine, Mag-tarmfonden, the Jane and Dan Olsson foundation, the Mjolkdroppen foundation, The Bengt Ihre research fellowship in gastroenterology, Karolinska Institutet foundations, the regional agreement on medical training and clinical research between Stockholm County Council and Karolinska Institutet (ALF), the Swedish Cancer Society, the Swedish Research Council, and the Swedish Foundation for Strategic Research. Publication: “Childhood-onset inflammatory bowel disease and risk of cancer – a Swedish nationwide cohort study 1964-2014” . Ola Olén, Johan Askling, Michael Sachs, Paolo Frumento, Martin Neovius, Karin Ekström Smedby, Anders Ekbom, Petter Malmborg and Jonas F Ludvigsson. The BMJ, online 21 September 2017, doi: 10.1136/bmj.j3951.

Alligator Bioscience to present ADC-1013 intratumoral clinical phase I study results at SITC in November 2017

Lund, Sweden, September 21, 2017 – Alligator Bioscience (Nasdaq Stockholm: ATORX), a biotechnology company developing antibody-based pharmaceuticals for tumor-directed immunotherapy, announced today that results from a clinical phase I study of the drug candidate ADC-1013 (JNJ-64457107) will be presented at the Society for Immunotherapy of Cancer (SITC) 32nd Annual Meeting, held from 8-12 November 2017 at the Gaylord National Hotel & Convention Center in National Harbor, Maryland, US. Alligator Bioscience will give both an oral and poster presentation at the SITC conference with the title: “First-in-human study with intratumoral administration of a CD40 agonistic antibody: preliminary results with ADC-1013/JNJ-64457107 in advanced solid malignancies”. The oral presentation will be held at Session Clinical Trials: New Agents, starting at 1:45 p.m. ET (7:45 p.m. CET) on November 10, 2017. For further information about the program, please visit the conference web For further information:Cecilia Hofvander, Director Investor Relations & CommunicationsPhone +46 46 286 44 95E-mail: This release contains information that Alligator Bioscience AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 8:30 a.m. CEST on 21 September 2017. Notes to editors About ADC-1013 ADC-1013 is a drug candidate intended for immunotherapy of different types of cancer. Pre-clinical data have shown that the ADC-1013 antibody effectively activates T-cells, mediated through binding to the co-stimulatory receptor CD40 on dendritic cells. The increased T cell activation enables the immune system to attack the cancer. In addition, since some cancer cells express CD40 on the surface, ADC-1013 may act also through a secondary mechanism of action killing cancer cells directly.  In August 2015, Alligator licensed global development rights for ADC-1013 to Janssen Biotech Inc. In October 2016, Janssen Biotech, Inc. started a second phase I clinical study (ClinicalTrials: NCT02829099). That study is an intravenous dose escalation study with ADC-1013 (JNJ-64457107). About the ADC-1013 clinical Phase I study The study to be presented is a multicenter, open-label phase I study in patients with advanced solid tumors evaluating safety and tolerability, pharmacokinetics, immunogenicity, biomarker response and clinical response. The study is a dose-escalation study involving intratumoral and intravenous administration of ADC-1013 at five hospitals in Sweden, Denmark and the UK. The study was performed by Alligator and includes 24 patients and ten different tumor types. For further information, please visit; NCT02379741. About Alligator Bioscience Alligator Bioscience AB is a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs. Alligator’s growing pipeline includes lead clinical and pre-clinical drug candidates (ADC-1013, ATOR-1015, ATOR-1017, and ALG.APV-527) and novel research candidates. ADC-1013 (JNJ-64457107) is licensed to Janssen Biotech, Inc., part of J&J, for global development and commercialization. Alligator’s shares are listed on Nasdaq Stockholm (ATORX). The Company is headquartered in Lund, Sweden, and has approximately 45 employees. For more information, please visit .

NextCell Pharma receives wholesale distribution authorisation

CEO Mathias Svahn says “This license is a good next step towards the start of our first clinical trial with ProTrans™ for the treatment of patients with Type 1 diabetes”. About the clinical trial: The study is divided into two parts: The first part is a three-step dose escalation with three patients in each, a total of 9 patients. The second part is randomized, double-blind, placebo-controlled study where 10 patients receive ProTrans and 5 patients receive placebo, a total of 15 patients. Primary safety endpoint is safety at 3 months and primary efficacy endpoint is change in insulin production after 1 year. The study sponsor of the proposed clinical trial related to the wholesale distribution is NextCell and the principal investigator is Professor Per-Ola Carlsson, who works at Uppsala University and the Academic Hospital in Uppsala. The study will be conducted together with Karolinska Trial Alliance (KTA), which holds great expertise in performing cell therapy clinical trials. Treatments are scheduled to take place at the KTA Phase I unit located at Karolinska University Hospital in Huddinge. Ulf Smith MD, PhD, Professor and Director, Lundberg Laboratory for Diabetes Research, Sahlgrenska Academy and Sahlgrenska University Hospital, Gothenburg; Anders Fasth MD, PhD, Professor of Pediatric Immunology, Sahlgrenska Academy and Chief Physician at Drottning Silvias Children's Hospital, University of Gothenburg; and Åke Lernmark PhD, Professor and Principal Investigator in Diabetes and Coeliac, MAS, Lund University; will together make up the Data Safety Monitoring Board with Ulf Smith as Chairman.  This information is the information that NextCell Pharma AB is required to disclose under the EU Market Abuse Regulation. The information was provided by the above contact person for publication on September 21st, 2017.


Daryl C. Plummer is Managing Vice President, Chief of Research and a Gartner Fellow. Playing a pivotal research role in Gartner’s comprehensive industry and technology predictions, Daryl has over 35 years’ experience on a strategic, executive and state level in IT and computing. As Chief of Research for emerging trends at Gartner Daryl leads all research into cloud computing and is a primary analyst on business process management, SOA and Web. At the IFS World Conference he will in his keynote connect you to what’s next in an ever-transforming world. Amy McWhirter is a dynamic professional trade show presenter, consultant and event MC, engaging audiences with attention-grabbing, consistently energetic presentations. Amy has expert experience in cybersecurity, manufacturing, healthcare & medical, IT, construction, and other industries for both innovative startups, mid-level corporations and Fortune Global 500's. In addition to being an event moderator (MC), Amy has a background as film producer and professional broadcaster, and has hosted major events for many of the world’s most innovative technology companies. As the conference moderator, Amy will guide the visitors through three action-packed days full of news, learning experiences and networking. Mark Boulton, Chief Marketing Officer (CMO) of IFS comments: ”The IFS World Conference 2018 will be a fantastic opportunity for customers, partners and prospects to meet with experts, learn about the latest news and share experiences with their peers. Daryl C. Plummer and Amy McWhirter will lift the conference to a new level by providing unique perspectives and insights as well as inspiring a new train of thought for what´s next for your business.” For more information about the IFS World Conference 2018 and to register, please visit:

New film from Google shows the value of Camanio Care’s technology

The film can be seen on the link here.   BikeAround™ jDome is a development of the traditional exercise bike. When riding the bicycle a street view is projected in front of the person. Through Google Street View the cycling tracks become endless and the user can experience everything from large cities to former neighborhoods. - We are of course very proud of the fact that Google creates a film showing the strong values of our product BikeAround jDome. In addition, the film is very well-made and with a warm personal story based on care and love, says Catharina Borgenstierna, CEO Camanio Care. In the film The BikeAround jDome we get to know Bengt and Laila from Tibro. Bengt has Alzheimer’s disease. Thanks to the BikeAround jDome, this man is able to go back in time, to places he remembers from old days and can very naturally ride his bike through these memories. The strong experiences are combined with physical activity. Research is currently on-going to study the effects that this kind of multisensory stimulation can have for the brain. BikeAround jDome is one of several products within robotics and welfare technology from Camanio Care, which contributes to a better living for elderly and disabled people. At this moment, several residential homes in Sweden are using BikeAround jDome and interest is also increasing in the global market. -          With the boost of Google's new film, we hope to reach even more stakeholders around the world. In the end giving more elderly people a chance to benefit from our care technology. As well as developing the future of health care, concludes Catharina Borgenstierna For further information, please contact:Catharina Borgenstierna, CEOEmail: About Camanio CareCamanio Care is a company in welfare technology with products in robotics, augmented reality and online services that focus on people's basic needs. Today we offer solutions that increase quality in the areas of activation, meal, safety and communication, such as jDome BikeAround, Giraffe and Bestic. Camanio Care currently has its head office in Stockholm, a subsidiary in the United States and distributors in China, Denmark, Finland, Norway, Netherlands, UK, Spain, France, Germany, Italy and Australia. Subscribe to our newsletter and read more about the company on our website 

RaySearch completes major expansion of RayStation platform at Princess Margaret Cancer Centre

University Health Network’s Princess Margaret Cancer Centre (PMH) in Toronto, Canada has increased the number of RayStation licenses as part of a phased approach to full implementation of the RaySearch Treatment Planning System. The purchase also includes RayStation’s Plan Explorer functionality, which makes it possible to automatically generate a large number of plans for defined clinical goals and combinations of treatment techniques and machines. The purchase covers the core RayStation technologies –3D-CRT, IMRT, VMAT, deformable registration, dose tracking and multi-criteria optimization along with some additional technologies such as radiobiology and virtual simulation. PMH has decided to implement six Plan Explorer licenses to determine how the new technology might further streamline planning, both in terms of automation and exploring possible treatment solutions. Dr. Fei-Fei Liu, Chief of the Radiation Medicine Program at PMH says: “The team at Princess Margaret Cancer Centre has done a lot of work and retrospective analyses to determine the best technologies and treatment approaches for the future. We are very optimistic about how we can implement adaptive radiation therapy and further automate treatment planning to optimize our treatment approaches and improve care for our patients. We believe these technologies will continue to allow us to create high quality treatment plans, more efficiently than ever before.” Johan Löf, CEO of RaySearch, says: “We have an excellent and longstanding partnership with PMH and I am delighted to be able to support them in developing tomorrow’s cancer treatment approaches. With this agreement, PMH is on the way to being one of the biggest RayStation installations in the world.” About Princess Margaret Cancer Centre, University Health NetworkThe Princess Margaret Cancer Centre has achieved an international reputation as a global leader in the fight against cancer and delivering personalized cancer medicine. The Princess Margaret, one of the top five international cancer research centres, is a member of the University Health Network, which also includes Toronto General Hospital, Toronto Western Hospital, Toronto Rehabilitation Institute and the Michener Institute for Education; all affiliated with the University of Toronto. For more information, go to or About RayStationRayStation integrates all RaySearch’s advanced treatment planning solutions into a flexible treatment planning system. It combines unique features such as multi-criteria optimization tools with full support for 4D adaptive radiation therapy. It also includes functionality such as RaySearch’s market-leading algorithms for IMRT and VMAT optimization and highly accurate dose engines for photon, electron, proton and carbon ion therapy. The system is built on the latest software architecture and features a graphical user interface with state-of-the-art usability. About RaySearchRaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation treatment planning system to clinics all over the world and distributes products through licensing agreements with leading medical technology companies. The company is also developing the next-generation oncology information system, RayCare*, which comprises a new product area for RaySearch, and which will be launched in December 2017. RaySearch’s software is used by over 2,600 clinics in more than 65 countries. The company was founded in 2000 as a spin-off from Karolinska Institutet in Stockholm and the share has been listed on NASDAQ Stockholm since November 2003. More information about RaySearch is available at * Subject to regulatory clearance in some markets. For further information, please contact:Johan Löf, President and CEO, RaySearch Laboratories AB (publ)Telephone: +46 (0)8-510 530

NeuroVive receives positive EMA Scientific Advice on its NeuroSTAT development plan for TBI

Following the top line results from the company’s clinical phase IIa CHIC (Copenhagen Head Injury Ciclosporin) study, conducted at Rigshospitalet in Copenhagen, Denmark, and the positive results from the preclinical studies, done in collaboration with the University of Pennsylvania (Penn), USA, NeuroVive requested Scientific Advice with EMA on the continued clinical development program to bring NeuroSTAT to the market for treatment of moderate to severe TBI, including the design of the planned Phase IIb proof of concept study with NeuroSTAT.   The EMA Scientific Advice feedback is supportive of the novel design NeuroVive has proposed for its efficacy studies, including advanced imaging assessments of the protective effect of NeuroSTAT on brain cells. Furthermore, a subpopulation of the patient population will be selected with similar types of injury to the brain which facilitates evaluation of efficacy. NeuroSTAT has received orphan drug designation status (ODD) from both EMA and the U.S. Food and Drug Administration (FDA). “The feedback from EMA is very encouraging in moving our development program forward effectively since the design of our innovative proof of concept study including the endpoints and patient population were endorsed. This will potentially be beneficial in bringing our new treatment opportunity, NeuroSTAT, to the TBI patients who need it. Moreover, the introduction of novel designs and measures may be useful in the development of other TBI clinical projects”, said Magnus Hansson, Chief Medical Officer at NeuroVive. “The positive response from EMA is an important and valuable validation of our NeuroSTAT clinical development program, which is helpful as we will now approach FDA for formal advice”, said Erik Kinnman, CEO at NeuroVive.  “We are also intensifying our efforts in forming strategic alliances and applying for supportive non-dilutive co-funding of the Phase IIb NeuroSTAT proof of concept clinical study as we continue to develop this novel treatment opportunity for patients with TBI, an area of high unmet medical need”, he continued. This information is information that NeuroVive Pharmaceutical AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 11.30 a.m. CEST on 21 September 2017.

Four projects in running for the Kasper Salin Prize for Best Building of the Year

“The nominated projects show, for each in their own scale and varying prerequisites, the results of exceptionally good architectural effort. They each provide inspired and detailed answers to functional requirements, technical solutions and design, regardless of architectural features. This speaks for these buildings serving well over time, making them truly sustainable,” said the Jury Chair Bolle Tham, founder of Tham & Videgård Arkitekter. The Kasper Salin Prize has been awarded to a chosen building every year since 1962 by Architects Sweden. The jury includes experienced and highly reputable architects who conduct in-depth research and on-site study of each building. This year the Architectural Awards of Architects Sweden will be held 28 November at the Cirkus in Stockholm. The nominees are: Trädgårdarna, elderly care housing in Örebro. Architect: Marge Arkitekter, with senior architects MSA Susanne Ramel, Linda Björn and Katarina Grundsell. Commissioned by: Örebro Municipality through Marie Villman and Skanska Sverige through Thorbjörn Lindvall. Landmäreskolan in Gothenburg. Architect:  Wahlström & Steijner Arkitekter, through senior architect MSA Jürgen Wahlström. Commissioned by: Lokalförvaltningen, City of Gothenburg, through Charlotte Odbratt. Bruksgården, expansion wing in Höganäs. Architect: Architect MSA Petra Gipp. Commissioned by: Lindéngruppen, through Jenny Lindén Urnes. Museum of Sketches for Public Art in Lund, new entrance and restaurant. Architect: Elding Oscarson, through senior architects MSA Jonas Elding and Johan Oscarson. Commissioned by: Statens Fastighetsverk (National Property Board). “The jury’s work clearly identifies the critical value of initial architectural decisions in ensuring that the concept can withstand the challenges presented by the process of completing the building. This is naturally impacted by the developer's attitudes and this appears to be common to each of the nominated projects – the architect has been entrusted to lead activities throughout,” added Mr. Tham.  This year's jury included Bolle Tham, Architect SAR/MSA, Tham & Videgård Arkitekter, Ewa Westermark, Architect SAR/MSA, Gehl Architects, Monica von Schmalense, Architect SAR/MSA, White Arkitekter, and Thomas Sandell, Architect SIR/MSA SAR/MSA, Sandellsandberg Arkitekter.

Nexam Chemical´s patent application relating to a cross-linkable nylon to be allowed in Europe

Nexam Chemical´s crosslinking technology, which includes a number of unique crosslinking systems, results in improved processability of plastics at the same time as properties such as heat and chemical resistance is improved. The present application is related to new types of polyamides comprising NEXIMID® and NEXAMITE® cross-linkers and thereby having improved properties. The patent to issue will further strengthen Nexam Chemical´s position as a leading provider of additives, e.g. cross-linkers, for improving plastics. As previously announced, the corresponding application has already been granted in the US. Note: This press release has been translated from Swedish. The Swedish text shall govern for all purposes and prevail in case of any discrepancy with the English version. For further information please contact: Anders Spetz, CEO, +46-703 47 97 00, ___________________________________________________________________________ About Nexam Chemical Nexam Chemical develops technology and products that make it possible to significantly improve the production process and properties of most types of plastics in a cost-effective manner and with retained production technology. The improved properties include strength, toughness, temperature and chemical resistance as well as service life. The improvements in properties that can be achieved by using Nexam Chemical's technology make it possible to replace metals and other heavier or more expensive materials with plastics in a number of applications. In applications where plastic is already used, Nexam Chemicals products can improve the manufacturing process, reducing material use and enable more environmental friendly alternatives. Example of commercial applications: pipe manufacturing, foam production and high-performance plastics. More information about the business will be found on . The company´s Certified Adviser is FNCA Sweden AB.

Telia Company reaches a global settlement with the authorities regarding Uzbekistan investigation

“Today’s settlement brings an end to an unfortunate chapter in Telia Company’s history. Since 2013 the new board and management have worked diligently and responsibly to understand what went wrong, to remedy what has been broken and to regain trust from all our stakeholders. We have come a long way to establish a more sustainable company with a strong focus on governance and compliance but it is a never-ending journey as we aspire to embed this into our culture making sure that all employees understand the importance of doing the right thing all the time. The resolution and related financial sanction that we announce today is a painful reminder of what happens if we don't”, says Telia Company’s President and CEO Johan Dennelind. The U.S. and Dutch authorities conclude that Telia Company’s conduct was in violation of the FCPA (Foreign Corrupt Practices Act) and Dutch legislation and that corrupt payments of approximately USD 330 million were made by the company. As part of the settlements, Telia Company will pay fines and disgorgements to the SEC, DOJ and OM in an aggregate amount of USD 965 million. In addition, Telia Company’s subsidiary in Uzbekistan, Coscom LLC, has entered a guilty plea with the DOJ. The total fine has been determined to be USD 548 million which is paid in equal parts to the DOJ and OM. In addition, the financial gain has been calculated to be USD 457 million and the equivalent amount will be disgorged except for USD 40 million which is part of the amount to be paid as a forfetuire to the DOJ. This SEC disgorgement amount will be offset by up to USD 208.5 million against any disgorgement obtained by the Swedish Prosecutor or Dutch authorities. Since receiving the initial resolution proposal from the U.S. and Dutch authorities in September last year, Telia Company has engaged in constructive discussions with each authority and this has resulted in a resolution that is in the best interests of the Company. Telia Company’s cooperation in the investigation and its extensive remedial measures, including terminating all individuals involved in the misconduct; creating a new and robust compliance function throughout the company; implementing a comprehensive anti-corruption program and overhauling the Company’s corporate governance structure has been recognized by the authorities. Telia Company received an aggregate discount of 25% off of the bottom of the otherwise-applicable U.S. Sentencing Guidelines fine range. Based on the Company’s remediation and the state of its compliance program, the authorities determined that an independent compliance monitor was unnecessary. Telia Company will continue to cooperate with the authorities and has committed to continuing to enhance its compliance program and internal controls. Telia Company was informed in March 2014 that U.S. and Dutch authorities were investigating its historical transactions in Uzbekistan and its dealings with Takilant Ltd – Telia Company’s local partner when the Company entered Uzbekistan in 2007. Since 2012, a Swedish prosecutor has separately investigated the transactions as well. Telia Company has continuously cooperated fully with and supported the investigations. “Telia Company is pleased to be able to bring closure to what has been a very serious and difficult process. The company has done everything in its power to take responsibility for actions in connection to the entrance into Uzbekistan ten years ago and the subsequent transactions involving Takilant. Our ambition throughout the entire process has been to be as transparent as possible and to establish a trustful co-operation with the authorities in question. We have accounted for our solid sustainability work and the major cultural changes that have taken place within the Company during the last few years which have been important factors enabling us to have a constructive dialogue and for the outcome of the settlement. These changes within the company are also a very important platform for shaping the new Telia Company,” says Marie Ehrling, Chair of the Board of Telia Company. The settlement announced today relates to the question of the Company’s responsibility for its previous wrongdoings, not if there may be individuals that have a liability for related events. The Swedish prosecutor’s investigation into individuals is still ongoing and the Company may be subject to disgorgement proceedings resulting from that investigation. Telia Company continuously considers all possibilities to protect the rights and interests of the Company.  Analyst telephone conference September 21, at 20.45 CET in EnglishWith Marie Ehrling, Chair of the Board, Johan Dennelind, President and CEO of Telia Company, Christian Luiga, CFO, and Jonas Bengtsson, Group General Counsel. Presentation material will be available ahead of the conference call at Dial-in number: +44 (0) 1452 555 566, 0800 694 0257Access code: 90176607 You can also listen to the conference call afterwards.Replay number: +44 (0) 1452 550 000Access code: 90176607  Press Meeting September 22, at 10.00 CET in Swedish Place: Telia Company’s Head Office, Stjärntorget 1, SolnaMarie Ehrling, Chair of the Board of Telia Company, Johan Dennelind, President and CEO, and Jonas Bengtsson, Group General Counsel, will participate.  This information is information that Telia Company AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 20:00 CET on September 21 2017.  For more information, please contact our press office +46 771 77 58 30, visit our Newsroom  or follow us on Twitter @Teliacompany  .  Forward-Looking StatementsStatements made in the press release relating to future status or circumstances, including future performance and other trend projections are forward-looking statements. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. There can be no assurance that actual results will not differ materially from those expressed or implied by these forward-looking statements due to many factors, many of which are outside the control of Telia Company.  We’re Telia Company, the New Generation Telco. Our 21,000 talented colleagues serve millions of customers every day in one of the world’s most connected regions. With a strong connectivity base, we’re the hub in the digital ecosystem, empowering people, companies and societies to stay in touch with everything that matters 24/7/365 - on their terms. Headquartered in Stockholm, the heart of innovation and technology, we’re set to change the industry and bring the world even closer for our customers. Read more at 

Axactor AB - Publication of prospectus

Oslo, 21 September 2017 - Reference is made to the stock exchange notices from Axactor AB ("AXA" or the "Company") published 14 August 2017, regarding the successful completion of the private placement of 240 million new shares in the Company (the "Private Placement") and the entering into a co-investment partnership with Geveran. The Swedish Financial Supervisory Authority has approved the prospectus of the Company dated 21 September 2017 (the "Prospectus"), for the listing of 164,400,000 Private Placement Tranche 2 Shares to be issued in connection with the Private Placement, each with a par value of EUR 0.0523. The Prospectus can be obtained electronically by downloading it from The share capital increase in connection with the Private Placement Tranche 2 Shares is expected to be registered in the Swedish Companies Registry on or about 26 September 2017. Shares allocated in Tranche 2 are not tradable until the share capital increase is registered and announced by a stock exchange notice. The Private Placement Tranche 2 Shares will be settled through a delivery versus payment transaction following the registration of the share capital increase in the Swedish Companies Registry. DNB Markets acted as manager in the Private Placement. For additional information, please contact: Endre Rangnes, CEO Axactor Mobile phone: +47 4822 1111 Email: or Geir Johansen, CFO & Investor Relations, Axactor Mobile phone: +47 4771 0451 Email: About Axactor Axactor Group specializes in both Debt Collection and Debt Purchasing across several countries, with operations in Italy, Germany, Norway, Sweden and Spain. The company has a Nordic base and an ambitious Pan-European growth strategy, which targets the market for non-performing loans (NPL) in Europe. This market is estimated to be about 1,500 billion euros across Europe providing significant opportunities for Axactor's future expansion. Axactor has approximately 888 employees.

Regarding potential large scale energy storage project in Fredericia, Denmark

(Oslo, 22 September 2017) Reference is made to the media report regarding a potential large scale energy storage project at an oil refinery in Fredericia, Denmark, were Nel ASA (Nel, OSE:NEL) is named as potential party. Nel has worked with local partners to explore the options for establishing Europe´s largest hydrogen electrolyser in Fredericia. Recently the Danish Social Democrats announced their intention to support the allocating of public funds for the project. The media report from the local paper Fredericia Dagblad is available here (Danish): The Fredericia project would entail the establishment of a large-scale electrolysis plant from Nel. The electrolyser would use green electricity to produce hydrogen and oxygen for the local oil refinery, heat for the city of Fredericia as well as hydrogen fuel for cars and busses in Denmark. Member of Parliament from the Danish Social Democrats, Jesper Petersen is quoted in the media report, that as part of political negotiations, the Social Democrats will propose that public funds are allocated for the Fredericia project. “An oil refinery uses significant amounts of hydrogen in the refinery process. This hydrogen is traditionally based on fossil sources. However, when switching to renewable hydrogen this initiative alone will help to reduce the CO2 footprint of the refinery itself as well as the associated products supplied out of the refinery. We are pleased to see the political support for the project and look forward to continue progressing this exiting and promising project with our partners,” says Jacob Krogsgaard, Senior Vice President in Nel. If the project is realised, Nel and the partners in the project will be able to provide energy storage to the Danish power grid whilst producing green hydrogen for both the local refinery, as well as hydrogen for general transportation purposes like cars and busses. “We have been working on this for some time and believe that our cost-effective electrolyser product portfolio would be ideal for this project. Not only is this an exciting project in itself, but the developed solution could naturally be relevant in many other oil refineries across the globe”, says Jon André Løkke, CEO of Nel.  ENDS For additional information, please contact: Jacob Krogsgaard, Senior Vice President, +45 2871 8945 Jon André Løkke, CEO, +47 907 44 949 About Nel ASA |         Nel is a global, dedicated hydrogen company, delivering optimal solutions to produce, store and distribute hydrogen from renewable energy. We serve industries, energy and gas companies with leading hydrogen technology. Since its foundation in 1927, Nel has a proud history of development and continual improvement of hydrogen plants. Our hydrogen solutions cover the entire value chain from hydrogen production technologies to manufacturing of hydrogen fueling stations, providing all fuel cell electric vehicles with the same fast fueling and long range as conventional vehicles today.

Starbreeze approved for listing on Nasdaq Stockholm

STOCKHOLM (22nd September 2017) The Nasdaq Stockholm Listing Committee has approved the admission of the Starbreeze share to start trading on Nasdaq Stockholm. The approval is conditional upon meeting certain conditions, including approval and registration of the prospectus by the Swedish Financial Supervisory Authority (“Finansinspektionen”). The Company’s assessment is that these conditions will be met as of the first day of trading on Nasdaq Stockholm, which is estimated to October 2nd 2017. The last day of trading on First North Premier is estimated to September 29th 2017. “The up-list to Nasdaq Stockholm is an important milestone for Starbreeze and the result of a goal-oriented effort. Starbreeze has had an amazing journey since 2014 when we were listed on First North Premier. Having previously operated only as a game developer working with external game publishers, we now own our internal product development and run a succesful publishing business with externally developed games to broaden our portfolio. We’ve also expanded the business ventures in the Virtual Reality (VR) segment including the development of the StarVR head mounted display and by taking a stake in the location based VR market. Starbreeze is well-positioned for continued development towards becoming a leading provider of world-class experiences in the global entertainment industry,” says Starbreeze CEO Bo Klint Andersson. The Board and Management of the Company believe that listing of the Company’s shares on Nasdaq Stockholm is a logical and important step in the Company's development. An up-listing has the potential to attract a wider group of investors and improve conditions for increasing awareness of the Company and its products, as well as strengthening the Starbreeze brand. A listing will also give Starbreeze better access to Swedish and international capital markets and their institutional investors, which it has been estimated will promote the Company's continued growth and development. The Board and Management also believe that a listing of the Company’s shares will act as a quality stamp for Starbreeze, which can have positive impact on relationships with customers, suppliers, and partners, and ultimately increased shareholder’s value. Shareholders in the Company do not have to take any action in connection with the listing on Nasdaq Stockholm. The shares will be traded under the same tickers and ISIN codes as before: STAR A, SE 007158928 and STAR B, SE0005992831. A prospectus for the listing will be released on or near September 29th 2017 and published on the website,   Carnegie Investment Bank AB is acting as financial adviser to Starbreeze and the law firm Lindahl is the Company’s legal adviser in relation to the listing on Nasdaq Stockholm.

Indutrade acquires Inovatools Group

Indutrade has signed an agreement with the intent to acquire all of the shares in the German Inovatools Group (, with annual sales of approximately EUR 33 million. Inovatools, established in 1990, is a manufacturer of metal cutting tools. Its offering is centered around solid carbide end mills and tools. Customers are in the mechanical engineering industry, aeronautical engineering industry, automobile industry and tool manufacturing industry. Half of the group’s sales are exported, while the other half are sold to customers in Germany. Inovatools has subsidiaries in Italy, Spain, Portugal, Austria, the USA and Turkey. The group has some 200 employees. “Indutrade has gotten to know Inovatools over several years’ time, and we are impressed with the company’s fine performance. The acquisition of Inovatools will further strengthen our position in Germany,” comments Bo Annvik, President and CEO of Indutrade AB. Memo Ildirar, Managing Director of Inovatools, comments: “We see clear advantages of gaining a long-term and strong owner in Indutrade and plan for continued profitable growth from an international perspective.” The acquisition is contingent upon approval by the German Competition Authority, and possession is expected to be transferred in October/November 2017. Inovatools will be included in Indutrade’s Special Products business area. The acquisition is expected to have a marginally positive impact on Indutrade’s earnings per share. Stockholm, 22 September 2017 INDUTRADE AB (publ)

Changes in Tieto’s Leadership Team

Tieto Corporation STOCK EXCHANGE RELEASE 22 September 2017, 09.00 am EET Tieto is announcing changes in its Leadership Team and the Financial Services industry group. Per Johanson, Executive Vice President, Financial Services, has decided to pursue new opportunities outside Tieto. Christian Segersven has been appointed Executive Vice President to lead Financial Services and be a member of Tieto’s Leadership Team as of 1 October 2017. His current roles are Vice President, Country Head Financial Services Finland and Norway, and Global Head Insurance and Wealth Management Solutions at Tieto. Further details on the newly appointed Leadership Team member are available on Tieto’s website .  “I want to express my warmest thanks to Per Johanson for his valuable contribution to Tieto’s renewal over the last eight years. Per has been leading the Financial Services industry group, building Tieto’s business among banks, insurance companies and other financial institutions both in the Nordic countries and globally. His role has been important particularly in Sweden, where he has also been country manager for the past several years. I wish him all the best in his future endeavors,” says Kimmo Alkio, President and CEO, Tieto Corporation. Further information for investors: Tanja Lounevirta, Head of Investor Relations, +358 50 321 7510, tanja.lounevirta (at) Further information for the media: Kia Haring, Head of Global Communications, tel. +358 40 765 3700, kia.haring(at) DISTRIBUTION NASDAQ HelsinkiPrincipal Media Tieto aims to capture the significant opportunities of the data-driven world and turn them into lifelong value for people, business and society. We aim to be customers’ first choice for business renewal by combining our software and services capabilities with a strong drive for co-innovation and ecosystems. Headquartered in Finland, Tieto has over 13 000 experts in close to 20 countries. Tieto’s turnover is approximately EUR 1.5 billion and shares listed on NASDAQ in Helsinki and Stockholm. 


The shares that were subscribes in Sotkamo Silver AB(publ.) through the warrants (TO4) with the subscription that was ended on August 31st are now registred and from September 22nd 2017, listed and possible to trade on Nasdaq Helsinki (Trading code: SOSI1). The shares on NGM Equity in Sweden has been traded since 18th September 2017 (Trading code: SOSI). The total number of shares and votes in Sotkamo Silver amounts to 119,313,694 and the share capital to SEK 163,679,896.48 each share with a quota value of approximately SEK 1.37. Stockholm 22th September 2017 This information is information that Sotkamo Silver AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 08.45 CEST on 22th September 2017. Contact personTimo Lindborg, CEO of Sotkamo Silver AB, tel. +358 40 508 3507 The official Stock Exchange Releases are given in Swedish and there may be differences in the translated versions. About Sotkamo Silver AB Sotkamo Silver AB´s business concept is to exploit mineral deposits in the Nordic countries with positive social and environmental benefits. Sotkamo Silver owns mineral deposits, which contain silver and gold in Finland as well as zinc and gold in Norway. The Company’s main development project is the Silver Mine project in the municipality of Sotkamo. Sotkamo Silver applies SveMin’s & FinnMin’s respective rules of reporting for public mining & exploration companies. Sotkamo Silver has chosen to report mineral resources and ore reserves according to the internationally accepted JORC or NI 43-101 code. The company applies International Financial Reporting Standards (IFRS) as approved by the European Union. The ticker symbol is SOSI in NGM Equity in Stockholm and SOSI1 in NASDAQ OMX Helsinki. ISIN-code for Sotkamo Silver shares is SE0001057910.Legal Entity Identifier (LEI) number: 213800R2TQW1OZGYDX93 The Company's press releases and financial reports are distributed via Cision Sverige and are available on


London – 22 September 2017 - The Board of The Marketing Group PLC (“TMG” or the “Group”) notes the decision of the NASDAQ Stockholm's Disciplinary Committee to censure and fine TMG for historic breaches of the NASDAQ First North Rules. The current Board of TMG fully accepts the Disciplinary Board’s conclusions and that these rule breaches took place. The rule breaches detailed in the NASDAQ Stockholm's Disciplinary Committee notice took place prior to the appointment of the current TMG Board of Directors and since their appointment systems, procedures and controls have been put in place to ensure, as far as possible, that no further rule breaches will occur. Under a contract entered into between the Group and former Board members, Messers Harbour, Laing and Street, the Board is advised that the Group is fully indemnified against the cost of the fine imposed and will be taking all reasonable steps to ensure that the cost is recovered as soon as possible from these individuals. TMG today is a very different group to the one when the rule breaches took place.  Under the direction of the current Board a new strategy is being implemented and the bulk of the internal reorganisation has been completed to address underperforming areas of the Group and other issues. Now that this period of internal focus is complete the Board’s focus is on accelerating sustainable growth. Adam Graham, CEO, TMG commented: “We note the decision of the NASDAQ Stockholm's Disciplinary Committee and fully accept their conclusions. The Rule breaches took place prior to the appointment of the current Board and we are indemnified against the financial penalty imposed on the Group. “We are confident that we have dealt with the legacy issues and that TMG is in a stronger position than it has ever been. Historic failings have been addressed and a cohesive global marketing group is being established that I believe will deliver strong long-term shareholder value. I look forward to the future with optimism and to making further announcements concerning our progress in due course.” -ENDS- For more information, please contactAdam Graham, CEOEmail: MediaJaime CarronPhone: 0207 1481606Email: Investor relationsClaes Delin / Mikael WidellPhone: +46 703 11 9960E-mail: This information is information that The Marketing Group plc is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, at 8.10am CET on 22 September 2017. The Marketing Group plc (“TMG”) in brief    TMG is building a global full-service marketing network that respects the individual cultures of each agency that joins. By providing a supportive platform for growth, and an agile management approach, TMG aims to provide a fresh alternative to the big holding companies: Independent Spirit - Global scale. Each company within the group provides specialist marketing services brought together, within complementary communities of practice, to form an international network that can address a global market. The central team supports its subsidiaries through a lean and nimble structure that can respond quickly to change and provide highly effective solutions for clients. The Marketing Group is listed on Nasdaq First North, Stockholm. Mangold Fondkommission AB, +46 8-5030 15 50, is the company’s Certified Adviser and liquidity provider.

The Swedish Transport Administration (Trafikverket) signs a three year agreement with Advenica and place an initial ZoneGuard order of 1.9 MSEK

Trafikverkets order includes the SecuriCDS ZoneGuard platform to a value of 1.9 MSEK and is proof for Advenica’s capability to support government agencies and enterprises in their digitizing process. The order will be delivered start in September 2017 and be finished Q4 2017. "We are very pleased that Trafikverket chooses our cybersecurity platform for such an important part within critical infrastructure. It is a very complex task to connect different suppliers and solutions, while maintaining secure information exchange. With our solutions, organisations can meet their digitizing needs without jeopardizing information security", says Rune Bengtsson, VP Sales Enterprise, Advenica AB. Most cybersecurity solutions on the market are based on preventing unauthorized individuals from conducting unapproved activities. Contrary to that approach, Advenica´s ZoneGuard is specifically designed to interconnect separated IT-systems in a secure manner. By allowing information to be exchanged according to a well-defined policy, it simplifies for the user to improve information security, without lowering requirements for functionality. Besides preventing most cyberthreats, ZoneGuard also removes the risk of unauthorized information exchange due to human error. For further information, please contact: Einar Lindquist, CEO Advenica AB, +46 (0)704 29 98 39, einar.lindquist@advenica.comThis information is information that Advenica AB is obligated to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 09.20 a.m. CET on September 22th, 2017.

Disgorgement claims from the Swedish prosecutor

With regard to the Swedish Prosecution Authority’s decision, Telia Company will continue to consider all possibilities to protect the rights and interests of the Company.  As previously announced, Telia Company has a good and constructive co-operation with the Swedish Prosecution Authority and the Swedish Police in the investigations of suspected corruption and we are very confident in the prosecutors and their work.   Telia Company announced on 21 September that a global settlement had been reached with the U.S. Department of Justice (DOJ), Securities and Exchange Commission (SEC) and the Dutch Public Prosecution Service (Openbaar Ministerie, OM) relating to previously disclosed investigations regarding historical transactions in Uzbekistan. Telia Company has agreed to a total financial sanction of USD 965 million. The global resolution brings an end to all known corruption related investigations or inquiries into Telia Company.       For more information, please contact our press office +46 771 77 58 30, visit our Newsroom  or follow us on Twitter @Teliacompany .      We’re Telia Company, the New Generation Telco. Our 21,000 talented colleagues serve millions of customers every day in one of the world’s most connected regions. With a strong connectivity base, we’re the hub in the digital ecosystem, empowering people, companies and societies to stay in touch with everything that matters 24/7/365 - on their terms. Headquartered in Stockholm, the heart of innovation and technology, we’re set to change the industry and bring the world even closer for our customers. Read more at

Probi launches a tasty and convenient way of taking your daily probiotic supplement

Capsules and tablets are still the most common delivery formats in the probiotic supplement industry, but not all consumers embrace taking pills. To meet the demand for new, innovative application formats, Probi has developed a novel probiotic product formulation - Probi® Fast Melt. Probi® Fast Melt is a probiotic powder stick that melts directly in your mouth – no water needed. The powder comes in a fresh lemon flavor and offers a tasty and convenient way of taking your probiotic supplement. The stick-pack is easy-to-use and ideal for children, but also suitable for adults. The stick-pack has been developed to provide a product with a pleasant mouthfeel, one stick holding one daily dose. Probi®Fast Melt contains Probi´s patented and clinically documented probiotic strain LP299V®, but will also be available with other Probi strains. “Taste and flavor are driving consumption and are becoming an important differentiator also within Consumer Healthcare. We believe that, with Probi®Fast Melt, there is a fantastic opportunity for our customers to attract new consumer groups, particularly children, into the probiotic supplement category”, says Niklas Bjärum, President Probi USA, Global Sales & Marketing. Probi will present this newly launched product application at the major industry exhibitions, Supply Side West, in Las Vegas 25-29th September and CPhi, in Frankfurt 24-26th October. The first consumer product with the Probi®Fast Melt formulation will be launched in Sweden in October this year already, under the Probi Mage® brand, the leading probiotic supplement brand in Sweden. FOR FURTHER INFORMATION, CONTACT:Niklas Bjärum, President Probi USA, Global Sales & Marketing, tel +46 46 286 89 67, e-mail: niklas.bjarum@probi.comJohan Wahlqvist, Director Marketing & Sales Consumer Healthcare, tel +46 46 286 89 27, e-mail: ABOUT PROBIProbi is a world leader within probiotics. Our vision is to help people live healthier lives by delivering effective and well-documented probiotics, with proven health benefits based on scientific research. Probi offers dedicated probiotic expertise and partnership all the way from R&D to finished products for companies within the consumer healthcare and food industry. Our GMP certified manufacturing facilities produce probiotics in custom made formats with value-adding delivery technologies. Founded by scientists in Sweden 1991, Probi is a multinational company with 4 centers of excellence, active in more than 40 markets around the world and holding over 400 patents worldwide. Read more at 

Pressmeddelande - Climeon offentliggör notering på Nasdaq First North Premier och prospekt i samband därmed

Pressmeddelande den 22 september 2017 Climeon offentliggör notering på Nasdaq First North Premier och prospekt i samband därmed Climeon AB (publ) (”Climeon” eller ”Bolaget”) offentliggjorde den 15 september 2017 avsikten att notera Bolagets B-aktier på Nasdaq First North Premier (”Noteringen”) och samtidigt genomföra en nyemission av B-aktier för att finansiera Bolagets fortsatta tillväxt (”Erbjudandet”). I dag, den 22 september 2017, offentliggör Climeon att Bolaget går vidare med Noteringen och ett prospekt och villkoren för Erbjudandet och Noteringen i samband därmed. För fullständigt pressmeddelande följ länken Om Climeon AB (publ)Climeon tillhandahåller en teknik som tillvaratar energin i spillvärme från industrier samt lågtempererad geotermisk värme för att generera elektricitet. Bolaget mottog sin första order under 2015 och har sedan dess byggt upp en kundbas bestående av bland annat Viking Line, Virgin Voyages/Fincantieri, Maersk Line, CP Energy och SSAB. Det har nu nått ett stadium där Climeon har beprövat sin teknik och dess kommersiella gångbarhet genom upprepade beställningar från ledande aktörer inom ett flertal industrier. Produkten är patentskyddad och erbjuder marknadsledande prestanda inom sina applikationsområden. Climeon har även byggt upp en skalbar organisation med hög produktionskapacitet och en erfaren ledningsgrupp som är redo för snabb tillväxt. För ytterligare information, kontakta:Thomas Öström, VD, ClimeonMob: +46 708 94 96 05E-post: thomas.ostrom@climeon.comChristoffer Andersson, COO, ClimeonMob: +46 762 00 72 99E-post:

LINK Mobility Group ASA signs Term Sheet regarding acquisition of Totalconnect in Italy

LINK Mobility Group ASA ("LINK"), one of Europe's leading and fastest growing providers of B2C mobile messaging and mobile services, has entered into a term sheet regarding the acquisition of Italian mobile messaging company Archynet s.r.l. ("Totalconnect"). Totalconnect was established in 1998, and is located in Turin in Italy. Totalconnect has a strong position in the Italian market with direct interconnect with the Italian mobile operators. It is one of the leading mobile messaging and marketing providers in Italy and has launched many new services within this space over the last years. "I am glad to announce that we have taken our first step into the Italian market through the acquisition of Totalconnect. This is one of the pioneers within mobile messaging in Italy and has as strong customer base of more than 600 enterprise customers. Italy is an exciting market for LINK going forward, and I am sure that we will see large opportunities from introducing some of our more advanced mobile messaging and solution services. We will naturally look for additional opportunities in Italy to ensure that we reach our 40% market share ambition in this large and growing European market." says Arild E. Hustad, CEO of LINK. "I am very happy selling my company that I started in 1998 and joining LINK.  We see strong growth in the Italian market and I believe that teaming up with LINK and its portfolio of mobile solutions services that we shall continue to grow our business strongly going forward. I personally wanted to find an international partner to take my current business to the next level in Italy!" says Claudio Gioiosa, CEO of Totalconnect. The agreed enterprise value of the transaction is EUR 2.475 million, on a cash-free and debt-free basis and assuming a normalized level of working capital. The enterprise value is based on a normalized EBITDA of EUR 450,000 multiplied by a factor of 5.5.   The purchase price under the transaction will, subject to customary adjustments, expected to be settled as follows: - 1/3 of the purchase price in cash upon closing, - 1/3 of the purchase price as sellers' credit to be paid no later than 36 months from closing. Interest of 4.75% per annum is to be paid in quarterly arrears, and - 1/3 of the purchase price of shares in LINK valued at the share price at the Oslo Stock Exchange today. LINK intends to acquire all shares in Totalconnect from the seller Claudio Gioiosa, and the acquisition is conditional upon a satisfactory result of a due diligence process to be performed by LINK, and upon LINK and the seller agreeing on the terms and conditions of a final share purchase agreement for the consummation of the transaction, containing, inter alia, customary closing conditions. The acquisition is furthermore subject to approval of the Board of Directors of LINK. LINK has a solid cash position due to strong cash flow from its operations and the successful placement of a EUR 50 million bond in February 2017. The cash part of the transaction will thus be fully financed through LINK's corporate fund and bond. The transaction is expected to close on or about 15 November 2017. For further information, please contact:CEO Arild HustadLINK Mobility Group ASAarild.hustad@linkmobility.comMob: +47 95 24 09 30 About LINK Mobility Group ASA LINK is one of Europe's leading and fastest growing providers of B2C mobile messaging and mobile services. LINK believe strongly in the power of mobilizing the interaction between businesses and consumers and have developed a range of attractive solutions to meet this growing demand and market trend. LINK is headquartered in Oslo, and has offices in Oslo, Bergen, Stockholm, Malmö, Copenhagen, Kolding, Tampere, Helsinki, Madrid, Hamburg, Sofia, Riga and Tallinn. LINK has experienced stellar growth during the last years, in terms of both revenue and profits. In 2016 LINK delivered 3 billion mobile messages on behalf of its 6.300 customers, reporter a pro forma revenue of NOK 1 billion and had an adjusted EBITDA of NOK 122 million. About Totalconnect Totalconnect was established in 1998, and is direct connected to the Italian operators. Totalconnect is a Mobile Marketing services provider, serving clients in Italy as a reliable partner to setup mobile campaign and sending out mobile messages. This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Nel ASA: Receives additional order as part of the world’s largest PEM hydrogen electrolyser agreement

(Connecticut, 22 September 2017) Proton OnSite “Proton”, a subsidiary of Nel ASA (Nel, OSE:NEL), has received an additional order for an M Series, Megawatt scale, hydrogen electrolyzers from Guangdong Synergy Hydrogen Power Technology Co., Ltd. (“Synergy”) under the earlier announced agreement between the two companies. The order is the fourth system order under the agreement between Proton and Synergy, total agreement covers up to 13 MW-systems with a total value, including installation and associated services, of more than USD 22 million. “We are pleased to have received an additional order under the exclusive agreement with Synergy. This confirms the strong partnership between Nel/Proton, Synergy and the Yunfu government in the Guangdong Province of China. The market for heavy duty fuel cell trucks and busses are developing fast in China, and Nel/Proton are well positioned to support this rapidly growing market with both electrolysers and complete hydrogen refueling solutions,” says David Bow, Senior Vice President, Sales and Marketing. The order has a value of up to USD 1.8 million, including installation, commissioning, and other related services. The installations and commissioning will start towards the end of 2017 and continue into 2018. For additional information, please contact: Jon André Løkke, CEO, +47 907 44 949 Bjørn Simonsen, VP Market Development and Public Relations, +47 971 79 821 About Nel ASA |       Nel is a global, dedicated hydrogen company, delivering optimal solutions to produce, store and distribute hydrogen from renewable energy. We serve industries, energy and gas companies with leading hydrogen technology. Since its foundation in 1927, Nel has a proud history of development and continual improvement of hydrogen plants. Our hydrogen solutions cover the entire value chain from hydrogen production technologies to manufacturing of hydrogen fueling stations, providing all fuel cell electric vehicles with the same fast fueling and long range as conventional vehicles today.

ABB to acquire GE Industrial Solutions

–     Acquisition will strengthen ABB’s #2 global position in electrification –      Non-core GE business with significant value creation potential within ABB –      Expands ABB’s access to the North American market through deep customer relationships, large installed base and extensive distribution networks –      Long-term usage of GE brand agreed –      Purchase price of $2.6 billion –      Potential for annual cost synergies of approximately $200 million –      ABB and GE establish long-term, strategic supply relationship for ABB products –      Operational EPS accretive in year one –      Closing expected in H1 2018 ABB today announced the acquisition of GE Industrial Solutions, GE’s global electrification solutions business. GE Industrial Solutions has deep customer relationships in more than 100 countries and an established installed base with strong roots in North America, ABB’s biggest market. GE Industrial Solutions is headquartered in Atlanta, Georgia, and has about 13,500 employees around the world. In 2016, GE Industrial Solutions had revenues of approximately $2.7 billion, with an operational EBITDA margin of approximately 8 percent[1] and an operational EBITA margin of approximately 6 percent[1]. ABB will acquire GE Industrial Solutions for $2.6 billion; the transaction will be operationally accretive in year one. ABB expects to realize approximately $200 million of annual cost synergies in year five, which will be key in bringing GE Industrial Solutions to peer performance. As part of the transaction and overall value creation, ABB and GE have agreed to establish a long-term, strategic supply relationship for GE Industrial Solutions products and ABB products that GE sources today. “With GE Industrial Solutions, we strengthen our Number 2 position in electrification globally and expand our access to the attractive North American market,” said ABB CEO Ulrich Spiesshofer. “Combined with the long-term strategic supply relationship with GE, this transaction creates significant value for our shareholders.” He added: “Together with the GE Industrial Solutions team, we will execute our well-established plans in a disciplined way to bring this business as part of the global ABB family back to peer performance. With this next step of active portfolio management, we continue to shift ABB’s center of gravity, in line with our Next Level strategy, by strengthening competitiveness, mainly in the North American market, and lowering risk with an early-cycle business.” “This combination brings together two global businesses with a broad complement of electrical protection and distribution assets,” said John Flannery, CEO of GE. “ABB values our people, domain expertise, and our ability to operate in the segments where we have depth and experience. GE will also benefit through an expanded strategic supply relationship with ABB as the two companies work together.” GE Industrial Solutions will be integrated into ABB’s Electrification Products (EP) division, resulting in a unique global portfolio and very comprehensive offering for North American and global customers. They will benefit from ABB’s innovative technologies and the ABB Ability™ digital offering coupled with GE Industrial Solutions’ complementary solutions and market access. Included in the acquisition is a long-term right to use the GE brand. ABB will retain the GE Industrial Solutions management team and build upon its experienced sales force. After closing, this transaction will have an initial dampening effect to EP’s operational EBITA margin. ABB commits to returning EP to its target margin corridor of 15-19 percent during 2020. Tarak Mehta, President of ABB’s EP division, said: “This acquisition strengthens our position as partner of choice for electrification globally and in North America. We look forward to working with GE Industrial Solutions’ and ABB’s customers and channel partners to create new opportunities in this highly attractive core market for our division. We have a clear integration plan to realize the synergies of this combination and to bring our combined business back into the target margin corridor during 2020.” ABB’s EP division delivers more than 1.5 million products to customers around the world every day through a global network of channel partners and end-customers. EP offers a comprehensive portfolio of low- and medium-voltage products and solutions for a smarter, more reliable flow of electricity from substation to socket. Given this transaction, ABB has decided to put the previously announced share buyback program on hold. The transaction is expected to close in H1 2018, subject to customary regulatory clearances. Credit Suisse and Dyal Co. acted as financial advisors to ABB, and Davis Polk & Wardwell provided legal counsel. More information The press release and presentation slides are available on the ABB News Center at and on the Investor Relations homepage at  ABB will host a press conference today starting at 9:00 a.m. Central European Time (CET) (8:00 a.m. BST, 3:00 a.m. EDT). The event will be accessible by conference call. Callers from the UK should dial +44 207 107 06 13. From Sweden, the number to dial is +46 85 051 00 31, and from the rest of Europe, +41 58 310 50 00. Callers from the US and Canada should dial +1 866 291 41 66 (toll-free) or +1 631 570 56 13 (long-distance charges apply). Lines will be open 10-15 minutes before the start of the call. A conference call and webcast for analysts and investors is scheduled to begin today at 12:00 p.m. CET (11:00 a.m. BST, 6:00 a.m. EDT). Callers from the UK should dial +44 207 107 06 13. From Sweden, the number to dial is +46 85 051 00 31, and from the rest of Europe, +41 58 310 50 00. Callers from the US and Canada should dial +1 866 291 41 66 (toll-free) or +1 631 570 56 13 (long-distance charges apply). Callers are requested to phone in 10 minutes before the start of the call. The call will also be accessible on the ABB website and a recorded session will be available as a podcast one hour after the end of the conference call and can be downloaded from our website.  About GE Industrial Solutions Since Thomas Edison patented the world’s first circuit breaker, GE Industrial Solutions has been transforming the future of electrification. We design electrical solutions at the crossroads of digital and industrial – smart, rugged and equipped to control electricity from the grid to its point of use. Every day, we partner with our customers to solve their toughest energy challenges and reimagine industry in a way that only the world’s digital industrial company can. About GE GE (NYSE: GE) is the world’s Digital Industrial Company, transforming industry with software-defined machines and solutions that are connected, responsive and predictive. GE is organized around a global exchange of knowledge, the "GE Store," through which each business shares and accesses the same technology, markets, structure and intellect. Each invention further fuels innovation and application across our industrial sectors. With people, services, technology and scale, GE delivers better outcomes for customers by speaking the language of industry. About ABB ABB (ABBN: SIX Swiss Ex) is a pioneering technology leader in electrification products, robotics and motion, industrial automation and power grids, serving customers in utilities, industry and transport & infrastructure globally. Continuing more than a 125-year history of innovation, ABB today is writing the future of industrial digitalization and driving the Energy and Fourth Industrial Revolutions. ABB operates in more than 100 countries with about 136,000 employees.  ABB has invested more than $11 billion in the United States since 2010 and employs approximately 20,000 people across the country, with more than 60 R&D and manufacturing sites nationwide. Important notice about forward-looking information This press release contains "forward-looking statements" relating to the acquisition of GE Industrial Solutions by ABB. Such forward-looking statements can be identified by words such as plans, intends, expects, commits and other similar terms. Such forward-looking statements are based on current expectations and involve inherent risks and uncertainties, including factors that could delay, divert or change any of them, and could cause actual outcomes and results to differ materially from current expectations. No forward-looking statement can be guaranteed. Among other risks, there can be no guarantee that the acquisition will be completed, or if it is completed, that it will close within the anticipated time period or that the expected benefits of the acquisition will be realized. Forward-looking statements in the press release should be evaluated together with the many uncertainties that affect ABB's business, particularly those identified in the cautionary factors discussion in ABB's Annual Report on Form 20-F for the year ended December 31, 2016. ABB undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. ---------------------------------------------------------------------- [1]  2016 GE Industrial Solutions financial information adjusted to ABB financial definition

Nel ASA: Awarded USD 8.3 million Hydrogen Electrolyser Fueling Station Contract

(Oslo, 25 September 2017) Proton Onsite (Proton) and Nel Hydrogen Solutions, divisions of Nel ASA (Nel, OSE:NEL), have received a purchase order of USD 8.3 million on a combined hydrogen PEM electrolyser and H2Station® fueling solution for SunLine Transit Agency (SunLine) in California. The combined solution will have a hydrogen capacity of up to 900 kg per day, making it the world’s largest combined hydrogen production and fueling facility currently being contracted. SunLine will use the solution for fueling of their growing fleet of Fuel Cell Electric Buses operating in the Palm Springs area in California. “We are very pleased to have been awarded this contract to deliver a turnkey hydrogen production and fueling solution to SunLine that will provide zero-emission public transportation for the Palm Springs area and contribute to California’s climate efforts. This delivery highlights the combined strengths of Proton and Nel, using cutting-edge technology both within PEM electrolysis and heavy duty fueling solutions for buses,” says Jon André Løkke, Chief Executive Officer of Nel. The facility will be delivered turn-key, consisting of one Proton PEM M400 electrolyser, and two H2Station® units from Nel. The awarded contract has a total value of just over USD 8.3 million, with expected delivery and installation during 2018.   “The project is strategically important for Nel and Proton, as it shows our joint capability in delivering unparalleled hydrogen production and fueling solutions. The combined organization is well-positioned to be part of current and future initiatives needed to achieve California’s long-term renewable energy goals,” says Løkke.   The project is supported by the Californian Air Resources Board (CARB) under the California Climate Investments (CCI) program.    ENDS For additional information, please contact: Jon André Løkke, CEO, +47 907 44 949 Bjørn Simonsen, VP Market Development and Public Relations, +47 971 79 821 About Nel ASA |         Nel is a global, dedicated hydrogen company, delivering optimal solutions to produce, store and distribute hydrogen from renewable energy. We serve industries, energy and gas companies with leading hydrogen technology. Since its foundation in 1927, Nel has a proud history of development and continual improvement of hydrogen plants. Our hydrogen solutions cover the entire value chain from hydrogen production technologies to manufacturing of hydrogen fueling stations, providing all fuel cell electric vehicles with the same fast fueling and long range as conventional vehicles today.